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Others’ Publications about EHDI: December 2019 through April 2020
The Journal of Early Hearing Detection and Intervention (JEHDI) focuses on improving Early Hearing Detection and 
Intervention (EHDI) systems by publishing peer-reviewed articles describing current research, evidence-based practice, 
and standards of care that are relevant for newborn and early childhood hearing screening, diagnosis, support, early 
intervention, the medical home, information management, financing, and quality improvement.
Even though JEHDI is the only journal that focuses exclusively on improving EHDI systems, many other journals include 
some articles relevant to JEHDI’s aim. To help JEHDI readers stay up-to-date about information in other journals about 
improving EHDI programs, we provide titles and abstracts of recent publications that are relevant to EHDI systems. 
Articles are listed in alphabetical order by the last name of the first author and titles of all articles are hyperlinked to the 
source. 
The EHDI-relevant articles described in the following abstracts are from all over the world – demonstrating the global 
relevance of EHDI systems. Many of the following abstracts focus on screening and diagnosis, suggesting that the 
fundamentals of the EHDI system still need to be improved. Many other articles are breaking new ground and suggesting 
creative innovations. For example: 
•	 DeForte et al. described an app called Hear Me Read (HMR) which uses enhanced digital stories as therapy 
tools for speech, language, and literacy for children with hearing loss. The study evaluated the user experience 
of the HMR app through a focus group study with caregivers and their children. The findings suggest that such 
educational apps can be valuable for those with hearing loss who are pursuing listening and spoken language as 
a communication outcome.
•	 Diener et al. surveyed 365 caregivers whose children were being seen in an otolaryngology clinic at a tertiary 
pediatric hospital about their knowledge of and attitudes toward congenital Cytomegalovirus (cCMV) and cCMV 
screening. Caregivers frequently were unaware of cCMV and its implications. Attitudes toward cCMV screening 
generally were positive. A majority wanted to know if their child had cCMV even if asymptomatic and were willing 
to pay $20 for cCMV screening. The results suggested that education on epidemiology and impact of cCMV may 
benefit both prevention of infection and attitudes toward screening.
•	 Guo et al. evaluated the efficacy of concurrent hearing and genetic screening in a general 239,636 eligible infants. 
They found 548 infants with hearing loss based on the physiological hearing screening, 41 infants who passed the 
hearing screening but likely had hearing loss based on the genetic screen, and 570 infants at risk for ototoxicity 
which is undetectable by hearing screening. They concluded that genetic screening complements newborn 
hearing screening by improving the detection of infants at risk of hereditary hearing loss and ototoxicity, and by 
informing genotype-based clinical management for affected infants and their family members. 
•	 Kruyt et al. evaluated the efficacy of Bone-Anchored Hearing implants (BAHIs) in children based on 20 articles 
published between 2000 and 2017, encompassing 952 children with implants. They concluded that BAHIs are a 
safe method for hearing rehabilitation in children, although large differences between studies are observed. The 
outcomes of new surgical techniques and implant designs in the pediatric population seem promising, but more 
research is needed before definitive conclusions can be drawn.
•	 Le et al. examined the health related quality of life (HRQoL) in young children with low language or congenital 
hearing loss. Based on a sample of 108 children in Australia, they found that children with low language and 
with hearing loss had lower HRQoL than children with normal language; the worst HRQoL was experienced by 
children with both. They concluded that children with low language and congenital hearing loss might benefit from 
interventions targeting overall health and well-being, not just their impairments. 
•	 Rabiço-Costa et al. in a study conducted in Portugal assessed the incidence of hearing loss in 51 children after 
the exposure to platinum drugs used to treat central nervous system tumors. They found ototoxicity in 23.5% of 
the children. Even though the use of chemotherapy for such tumors has significantly improved cure and survival 
rates, the ototoxicity resulting from platinum-derived chemotherapy may accompany patients for the rest of their 
lives (see related article by van As et al.).
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•	 Tarhun examined the smoking habits of family members of 75 children with serious otitis media (SOM) and 50 
healthy controls. The correlation between SOM and passive smoke was statistically significantly positive. They 
concluded that the effect of passive smoking is a preventable and controllable risk factor in the etiology of the SOM.
Abstracts for all 100 articles are listed below.
Genes (Basel). 2020 Jan 27;11(2). pii: E132. doi: 10.3390/genes11020132. 
Enhancing Genetic Medicine: Rapid and Cost-Effective Molecular Diagnosis for a GJB2 
Founder Mutation for Hearing Impairment in Ghana.
Adadey SM, Tingang Wonkam E, Twumasi Aboagye E, Quansah D, Asante-Poku A, Quaye O, 
Amedofu GK, Awandare GA, Wonkam A.
ABSTRACT: In Ghana, gap-junction protein β 2 (GJB2) variants account for about 25.9% of familial hearing 
impairment (HI) cases. The GJB2-p.Arg143Trp (NM_004004.6:c.427C>T/OMIM: 121011.0009/rs80338948) 
variant remains the most frequent variant associated with congenital HI in Ghana, but has not yet been 
investigated in clinical practice. We therefore sought to design a rapid and cost-effective test to detect this variant. 
We sampled 20 hearing-impaired and 10 normal hearing family members from 8 families segregating autosomal 
recessive non syndromic HI. In addition, a total of 111 unrelated isolated individuals with HI were selected, as well 
as 50 normal hearing control participants. A restriction fragment length polymorphism (RFLP) test was designed, 
using the restriction enzyme NciI optimized and validated with Sanger sequencing, for rapid genotyping of the 
common GJB2-p.Arg143Trp variant. All hearing-impaired participants from 7/8 families were homozygous positive 
for the GJB2-p.Arg143Trp mutation using the NciI-RFLP test, which was confirmed with Sanger sequencing. The 
investigation of 111 individuals with isolated non-syndromic HI that were previously Sanger sequenced found 
that the sensitivity of the GJB2-p.Arg143Trp NciI-RFLP testing was 100%. All the 50 control subjects with normal 
hearing were found to be negative for the variant. Although the test is extremely valuable, it is not 100% specific 
because it cannot differentiate between other mutations at the recognition site of the restriction enzyme. The 
GJB2-p.Arg143Trp NciI-RFLP-based diagnostic test had a high sensitivity for genotyping the most common GJB2 
pathogenic and founder variant (p.Arg143Trp) within the Ghanaian populations. We recommend the adoption 
and implementation of this test for hearing impairment genetic clinical investigations to complement the newborn 
hearing screening 
Iran J Child Neurol. 2020 Winter;14(1):21-30. 
Well-Being and Coping Capacities of Adolescent Students with Hearing Loss in Mainstream 
Schools.
Adibsereshki N, Hatamizadeh N, Sajedi F, Kazemnejad A.
OBJECTIVES: Coping strategies used by adolescents has an important role in preventing or decreasing their 
stresses and also increasing their well-beings. This study aimed at evaluating the coping capacity and well-being 
of adolescent students with hearing loss in mainstream schools and also the correlations between their coping 
strategies and positive characteristics of well-being (engagement, perseverance, optimism, connectedness and 
happiness (EPOCH). 
MATERIALS & METHODS: In this correlational study, 122 adolescent students with hearing loss were randomly 
selected from mainstream schools. Data collection was done by EPOCH Measure of Adolescent Well-Being and 
the Ways of Coping Questionnaire (WAYS). The Spearman correlation coefficient was used for determining the 
correlations between variables. 
RESULTS: The mean scores of using different coping strategies varied from 1.36 in problem solving to 1.44 
in seeking support. Among the positive characteristics of well-being, happiness had the lowest (11.04) and 
connectedness showed the highest score (12.33). The findings also showed a significant correlation between 
all coping strategies and EPOCH, however there was a strong positive correlation between total coping strategy 
score and perseverance (0.648) and happiness (0.629). 
CONCLUSION: Based on the results, the score of happiness in students with hearing loss was the lowest among 
positive characteristics of well-being and also happiness showed a strong association with total scores in coping 
strategies. Accordingly, interventional studies are needed to examine whether training students with hearing loss 
to use coping strategies is effective in increasing their happiness and overall well-being.
BMC Pediatr. 2020 Apr 20;20(1):175. doi: 10.1186/s12887-020-02080-2. 
Parental knowledge and attitudes to childhood hearing loss and hearing services in Qassim, 
Saudi Arabia.
Alsudays AM, Alharbi AA, Althunayyan FS, Alsudays AA, Alanazy SM, Al-Wutay O, Alenezi MM.
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BACKGROUND: Successful audiology service delivery depends on support from the community, and agreement 
to utilize hearing healthcare programs. Assessment of parents’ awareness regarding hearing loss (HL) and 
audiology services is necessary for the development of suitable hearing programs for children. Previous studies 
reported that early detection and intervention for hearing problems are typically strongly supported by parents. 
The current study sought to evaluate parents’ knowledge and attitudes regarding childhood HL and hearing 
services. 
METHODS: A cross-sectional study conducted at five centers in Qassim region of Saudi Arabia. A self-report 
questionnaire was administered to collect demographic data in addition to 31 questions regarding the knowledge 
and attitudes of parents toward HL. IBM SPSS Statistics for Windows, Version 21 was used for data analysis. A 
p-value cut-off point of 0.05 at 95% CI was used to determine statistical significance. The analyses examined the 
association between socio-demographic characteristics and knowledge and attitudes toward HL using chi-square 
tests. 
RESULTS: 
Overall, participants included in this study were 243 participants. Of these, 105 (43.2%) were fathers, and 138 
(56.8%) were mothers. Ages ranged from 21 to 60+ years. Assessment of the prevalence of various aspects of 
knowledge and attitudes among parents toward childhood HL revealed that 103 participants (42.4%) possessed 
good knowledge, while 140 participants (57.6%) possessed poor knowledge. In contrast, the attitude analysis 
revealed that 224 participants (92.2%) expressed positive attitudes, while only 19 participants (07.8%) showed 
a negative attitude regarding audiology services. We found a significant association between age group and 
knowledge (p = 0.002). 
CONCLUSION: Most parents in our sample possessed poor knowledge regarding childhood HL. However, 
most parents expressed positive attitudes regarding audiology services. The current findings suggest a need to 
increase awareness among parents regarding childhood HL.
Indian J Pediatr. 2020 Apr 13. doi: 10.1007/s12098-020-03260-9 
Congenital Cytomegalovirus and Zika Infections.
Angueyra C, Abou Hatab H, Pathak A.
ABSTRACT: Congenital infections affecting newborn infants can have potentially devastating clinical outcomes. 
They are usually caused by viruses that infect mothers during pregnancy and are transmitted to the fetus or 
newborn during the prenatal, perinatal or postnatal periods. Congenital cytomegalovirus (cCMV) is the most 
common congenital infection affecting up to 2.5% of all live births. Even though most infected infants are 
asymptomatic at birth, cCMV is an important cause of neurodevelopmental impairment and represents the main 
cause of non-hereditary sensorineural hearing loss. Also, congenital Zika infection has emerged in recent years 
as a cause of microcephaly and neurodevelopmental delays. Currently, universal screening is not recommended 
for either infection in pregnant women or newborn infants. Therefore, screening for both conditions is based 
on multiple factors such as maternal immune status, exposure, and clinical manifestations of the infant. Use of 
antiviral medications on symptomatic cCMV has shown improvement in outcomes, in contrast with congenital 
Zika for which there are no therapeutic options available. Even though both viruses can be present in breast milk, 
there are no recommendations against breastfeeding in full-term infants. Close follow-up for affected infants is 
necessary to monitor for developmental delays and sensory impairments to implement interventional therapies at 
the earliest time possible.
Lang Speech Hear Serv Sch. 2020 Jan 8;51(1):68-73. doi: 10.1044/2019_LSHSS-OCHL-19-0025. 
Audiological Considerations for Managing Mild Bilateral or Unilateral Hearing Loss in Infants 
and Young Children.
Bagatto M.
PURPOSE: This clinical focus article describes considerations for recommending assistive hearing technology 
to infants and young children who have mild bilateral or unilateral hearing loss. These conditions present special 
challenges compared to bilateral permanent hearing losses that are moderate to profound in their degree in that 
the recommendation to proceed with technology is not as clear. 
CONCLUSION: Current clinical practice guidelines and protocols for pediatric hearing aid fitting recommend 
managing these conditions on a case-by-case basis. Descriptions of key considerations for recommending 
assistive hearing technology for infants and young children with mild bilateral hearing loss or unilateral hearing 
loss are offered herein.
Ear Hear. 2020 Mar 6. doi: 10.1097/AUD.0000000000000862. 
Perception of Child-Directed Versus Adult-Directed Emotional Speech in Pediatric Cochlear 
Implant Users.
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Barrett KC, Chatterjee M, Caldwell MT, Deroche MLD, Jiradejvong P, Kulkarni AM, Limb CJ.
OBJECTIVES: Cochlear implants (CIs) are remarkable in allowing individuals with severe to profound hearing 
loss to perceive speech. Despite these gains in speech understanding, however, CI users often struggle to 
perceive elements such as vocal emotion and prosody, as CIs are unable to transmit the spectro-temporal detail 
needed to decode affective cues. This issue becomes particularly important for children with CIs, but little is 
known about their emotional development. In a previous study, pediatric CI users showed deficits in voice emotion 
recognition with child-directed stimuli featuring exaggerated prosody. However, the large intersubject variability 
and differential developmental trajectory known in this population incited us to question the extent to which 
exaggerated prosody would facilitate performance in this task. Thus, the authors revisited the question with both 
adult-directed and child-directed stimuli. 
DESIGN: Vocal emotion recognition was measured using both child-directed (CDS) and adult-directed (ADS) 
speech conditions. Pediatric CI users, aged 7-19 years old, with no cognitive or visual impairments and who 
communicated through oral communication with English as the primary language participated in the experiment 
(n = 27). Stimuli comprised 12 sentences selected from the HINT database. The sentences were spoken by male 
and female talkers in a CDS or ADS manner, in each of the five target emotions (happy, sad, neutral, scared, and 
angry). The chosen sentences were semantically emotion-neutral. Percent correct emotion recognition scores 
were analyzed for each participant in each condition (CDS vs. ADS). Children also completed cognitive tests of 
nonverbal IQ and receptive vocabulary, while parents completed questionnaires of CI and hearing history. It was 
predicted that the reduced prosodic variations found in the ADS condition would result in lower vocal emotion 
recognition scores compared with the CDS condition. Moreover, it was hypothesized that cognitive factors, 
perceptual sensitivity to complex pitch changes, and elements of each child’s hearing history may serve as 
predictors of performance on vocal emotion recognition. 
RESULTS: Consistent with our hypothesis, pediatric CI users scored higher on CDS compared with ADS speech 
stimuli, suggesting that speaking with an exaggerated prosody-akin to “motherese”-may be a viable way to 
convey emotional content. Significant talker effects were also observed in that higher scores were found for 
the female talker for both conditions. Multiple regression analysis showed that nonverbal IQ was a significant 
predictor of CDS emotion recognition scores while Years using CI was a significant predictor of ADS scores. 
Confusion matrix analyses revealed a dependence of results on specific emotions; for the CDS condition’s female 
talker, participants had high sensitivity (d’ scores) to happy and low sensitivity to the neutral sentences while for 
the ADS condition, low sensitivity was found for the scared sentences. 
CONCLUSIONS: In general, participants had higher vocal emotion recognition to the CDS condition which 
also had more variability in pitch and intensity and thus more exaggerated prosody, in comparison to the ADS 
condition. Results suggest that pediatric CI users struggle with vocal emotion perception in general, particularly to 
adult-directed speech. The authors believe these results have broad implications for understanding how CI users 
perceive emotions both from an auditory communication standpoint and a socio-developmental perspective.
Int J Pediatr Otorhinolaryngol. 2020 Mar 24;134:110017. doi: 10.1016/j.ijporl.2020.110017.
Audiologic testing in children with Down Syndrome: Are current guidelines optimal?
Basonbul RA, Ronner EA, Rong A, Rong G, Cohen MS.
INTRODUCTION: Down Syndrome (DS) is a Tier 1 risk factor for hearing loss. Guidelines exist to ensure close 
monitoring of children with DS for hearing loss. It is important to consider the timing of testing in order to obtain 
meaningful audiologic data in this high-risk population. The purpose of this study is to present hearing outcomes 
for children with DS during the first 8 years of life and to assess these outcomes in the context of current 
screening guidelines. 
METHODS: Retrospective review of audiometric outcomes was conducted for children with DS age 8 or younger 
who presented to a multidisciplinary DS clinic between January 2014 to June 2017. Age at the time of testing, as 
well as test success rate and hearing loss type and severity were noted. 
RESULTS: 131 patients were included in the study, 52% of which were male. 36% of the patients failed their 
newborn hearing screening and only 9% of those subjects had normal hearing on subsequent testing. Most 
hearing loss identified was mild and conductive in nature. Inconclusive results were most likely to be obtained at 
6-10 months of age. 
CONCLUSION: Hearing loss is common among children with DS. To optimize the quality of testing and avoid the 
need for sedation in followup testing, routine follow-up hearing screening should be performed either before 6 
months of age or after 10 months of age.
Fetal Pediatr Pathol. 2020 Jan 25:1-10. doi: 10.1080/15513815.2019.1710788.
Negative Effects of Noise on NICU Graduates’ Cochlear Functions.
Beken S, Önal E, Gündüz B, Çakir U, Karagöz İ, Kemaloğlu YK.
AIM: To evaluate the adverse effects of noise on hearing. 
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METHDOS: Thirty-two infants that had been admitted to neonatal intensive care unit (NICU) and 25 healthy 
controls were included in this study. Noise levels were recorded continously during the hospitalization period. 
RESULTS: All healthy controls passed the hearing screening tests before discharge and on the sixth-month follow 
up. Hospitalized infants had lower “Distortion Product Auto Acoustic Emission Signal Noise Ratio” (DPOAE SNR) 
amplitudes (dB) at five frequencies (1001, 1501, 3003, 4004, 6006 Hz in both ears). DPOAE fail rates at 1001 Hz 
and 1501 Hz were higher than in hospitalized infants (81.8% and 50.0% vs 20.0% and 4.0%). Infants who failed 
the test at 1001 and 1501 Hz were exposed to noise above the recommended maximum level for longer periods 
of time. 
CONCLUSION: Hearing tests performed at sixth-months of life were adversely affected in NICU graduates.
J Speech Lang Hear Res. 2020 Jan 15;63(1):321-333. doi: 10.1044/2019_JSLHR-19-00230. 
Associations Between Parenting Stress, Language Comprehension, and Inhibitory Control in 
Children With Hearing Loss.
Blank A, Frush Holt R, Pisoni DB, Kronenberger WG.
PURPOSE: Parenting stress has been studied as a potential predictor of developmental outcomes in children 
with normal hearing and children who are deaf and hard of hearing. However, it is unclear how parenting stress 
might underlie at-risk spoken language and neurocognitive outcomes in this clinical pediatric population. We 
investigated parenting stress levels and the shared relations between parenting stress, language comprehension, 
and inhibitory control skills in children with and without hearing loss (HL) using a cross-sectional design. 
METHOD: Families of children with HL (n = 39) and with normal hearing (n = 41) were tested. Children completed 
an age-appropriate version of the Concepts & Following Directions subtest of the Clinical Evaluation of Language 
Fundamentals and the NIH Toolbox Flanker Test of Attention and Inhibitory control. Caregivers completed the 
Parenting Stress Index-Short Form 4. 
RESULTS: Parenting stress levels were not significantly different between parents of children with and without 
HL. A significant negative association was observed between parenting stress and our measure of language 
comprehension in children with HL. A negative association between parenting stress and inhibitory control skills 
was also found in families of children with HL, but not hearing children. The parenting stress-inhibitory control 
relationship was indirectly accounted for by delayed language comprehension skills in children with HL. 
CONCLUSION: Even at moderate levels of parenting stress similar to parents of children with normal hearing, 
increases in parenting stress were associated with lower scores on our measures of language comprehension 
and inhibitory control in children with HL. Thus, parenting stress may underlie some of the variability in at-risk 
pediatric HL outcomes.
Int J Pediatr Otorhinolaryngol. 2020 Apr 8;134:110039. doi: 10.1016/j.ijporl.2020.110039. 
Implementation of a neonatal hearing screening programme in three provinces in Albania.
Bussé AM, Qirjazi B, Goedegebure A, Toll M, Hoeve HL, Toçi E, Roshi E, Carr G, Simonsz HJ.
OBJECTIVES: The EUSCREEN study compares the cost-effectiveness of paediatric hearing screening 
programmes and aims to develop a cost-effectiveness model for this purpose. Alongside and informed by the 
development of the model, neonatal hearing screening (NHS) is implemented in Albania. We report on the first 
year. 
METHODS: An implementation plan was made addressing objectives, target population, screening protocol, 
screener training, screening devices, care pathways and follow up. NHS started January 1st, 2018 in four 
maternity hospitals: two in Tirana, one in Pogradec and one in Kukës, representing both urban and rural areas. 
OAE-OAE-aABR was used to screen well infants in maternity hospitals, whereas aABR-aABR was used in 
neonatal intensive care units and in mountainous Kukës for all infants. Screeners’ uptake and attitudes towards 
screening and quality of screening were assessed by distributing questionnaires and visiting the maternity 
hospitals. The result of screening, diagnostics, follow up and entry into early intervention were registered in a 
database and monitored. 
RESULTS: Screeners were keen to improve their skills in screening and considered NHS valuable for Albanian 
health care. The number of “fail” outcomes after the first screen was high initially but decreased to less than 
10% after eight months. In 2018, 11,507 infants were born in the four participating maternity hospitals, 10,925 
(94.9%) of whom were screened in the first step. For 486 infants the result of screening was not registered. For 
the first screen, ten parents declined, eight infants died and one infant was discharged before screening could 
be performed. In 1115 (10.2%) infants the test either could not be performed or the threshold was not reached; 
361 (32,4%) of these did not attend the second screen. For the third screen 31 (34.4%) out of 90 did not attend. 
Reasons given were: parents declined (124), lived too far from screening location (95), their infant died (11), had 
other health issues (7), or was screened in private clinic (17), no reason given (138). 
CONCLUSIONS: Implementation of NHS in Albania is feasible despite continuing challenges. Acceptance was high for 
the first screen. However, 32.4% of 1115 infants did not attend the second screen, after a “fail” outcome for the first test.
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Arch Dis Child. 2020 Feb;105(2):187-189. doi: 10.1136/archdischild-2018-315866. 
Risk factors for permanent childhood hearing impairment.
Butcher E, Dezateux C, Knowles RL.
OBJECTIVE: While several perinatal risk factors for permanent childhood hearing impairment (PCHI) are known, 
association with gestational length remains unclear. We hypothesised that shorter gestational length predicts 
higher PCHI risk. 
DESIGN: 19 504 participants from the UK Millennium Cohort Study (born 2000-2002, prior to newborn screening). 
METHODS: Multivariable discrete-time survival analysis to examine associations between parent-reported PCHI 
by age 11 years and gestational length, plus other prespecified factors. 
RESULTS: PCHI affected 2.1 per 1000 children (95% CI 1.5 to 3.0) by age 11; however, gestational length did 
not predict PCHI risk (HR, 95% CI 1.00, 0.98 to 1.03 per day increase). Risk was increased in those with neonatal 
illness, with or without admission to neonatal care (6.33, 2.27 to 17.63 and 2.62, 1.15 to 5.97, respectively), of 
Bangladeshi or Pakistani ethnicity (2.78, 1.06 to 7.31) or born to younger mothers (0.92, 0.87 to 0.97 per year). 
CONCLUSION: Neonatal illness, rather than gestational length, predicts PCHI risk. Further research should 
explore associations with ethnicity.
Int J Pediatr Otorhinolaryngol. 2020 Apr 10;134:110043. doi: 10.1016/j.ijporl.2020.110043. 
Etiological profile of hearing loss amongst Lithuanian pediatric cochlear implant users.
Byckova J, Mikstiene V, Kiveryte S, Mickeviciene V, Gromova M, Cernyte G, Mataityte-Dirziene J, 
Stumbrys D, Utkus A, Lesinskas E.
INTRODUCTION: Congenital sensorineural hearing loss is a heterogeneous disorder; its etiological profile varies 
between populations. Pathogenic variants of GJB2 gene are the major cause of non-syndromic hearing loss. 
Congenital cytomegalovirus infection (cCMV) is the most important prenatal etiological factor causing hearing loss 
and other disorders. Perinatal events, syndromes, postnatal infections or traumas are less common. Causes of 
the remaining one third of hearing loss cases are unknown. 
OBJECTIVES: To determine the etiological profile of hearing loss in pediatric cochlear implant users in Lithuanian 
population. 
METHODS: The data of 122 children (70 male/52 female; aged 7.6 ± 3.3 years) cochlear implant users were 
analysed. Medical records of all children recruited in Santaros Clinics (Vilnius, Lithuania) were analysed to identify 
prenatal, perinatal, or postnatal risk factors based on the adapted list proposed by the Joint Committee of Infant 
Hearing. Genetic counselling and testing according to the scheme were performed to 101 children. DNA of 117 
children was extracted from the DBS on Guthrie cards and CMV DNA detected using real time PCR. 
RESULTS: Non-syndromic hearing loss was diagnosed in 65 cases (53.3%), 58 of which were GJB2 gene-
associated; syndromic hearing loss was diagnosed to 8 children (6.6%). Perinatal (prematurity, low birth 
weight, hypoxia, hyperbilirubinemia, sepsis, ototoxicity, and meningitis) and postnatal (meningitis) risk factors 
were associated with hearing loss in 16 (13.1%) and 4 (3.3%) study participants respectively. CMV DNA was 
detected in 12 samples (9.8%). The cause of hearing loss remained unknown only for 17 (13.9%) children. 
CONCLUSIONS: The major cause of HL in the current study was GJB2 gene alterations. Only 14% of the cohort 
had congenital hearing loss of unknown origin.
Am J Audiol. 2020 Mar 24:1-5. doi: 10.1044/2020_AJA-19-00094. 
Deafness Gene Mutations in Newborns in the Foshan Area of South China With Bloodspot-
Based Genetic Screening Tests.
Cao S, Sha Y, Ke P, Li T, Yuan W, Huang X.
PURPOSE: The aim of this study was to determine the rate of deafness gene mutations in the Foshan area of 
South China. 
METHOD: We enrolled the infants delivered in Foshan Maternity and Children’s Healthcare Hospital. Deafness 
gene mutation was detected by HibriMax method. Our study tested 47,538 newborns within 3 days after birth, 
including 13 sites in four genes: GJB2 (c.35 del G, c.176 del 16, c.235 del C, c.299 del AT, c.155 del TCTG), 
GJB3 (c.583 C>T), SLC26A4 (c.2168 A>G, c.919-2 A>G, c.1299 C>T), and mtDNA 12S rRNA (m.1555 A>G, 
m.1494 C>T, m.12201 T>C, m.7445 A>G). The birth condition of infants was collected, including sex, low or high 
birth weight, twins, and premature delivery. 
RESULTS: In a total of 47,538 newborns, 1,415 were positively identified with deafness gene mutations. The total 
rate of the deafness gene mutation was 2.976%. The carrier rates of GJB2 (c.35 del G, c.176 del 16, c.235 del C, 
c.299 del AT, c.155 del TCTG), GJB3 (c.583 C>T), SLC26A4 (c.2168 A>G, c.919-2 A>G, c.1299 C>T), and mtDNA 
12S rRNA (m.1555 A>G, m.1494 C>T, m.12201 T>C, m.7445 A>G) mutations were 0.000%, 0.048%, 1.422%, 
0.185%, 0.000%, 0.076%, 0.116%, 0.755%, 0.160%, 0.187%, 0.021%, 0.000%, and 0.006%, respectively. 
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CONCLUSIONS: Our study showed that the c.235 del C GJB2 mutation was the leading deafness-related 
mutation in the Foshan area of South China. Deafness gene mutations screening in newborns detected by 
bloodspot-based genetic screening tests can help the diagnosis of newborn congenital hearing loss.
Int J Environ Res Public Health. 2020 Mar 17;17(6). pii: E1969. doi: 10.3390/ijerph17061969. 
Increased Risk of Sensorineural Hearing Loss as a Result of Exposure to Air Pollution.
Chang KH, Tsai SC, Lee CY, Chou RH, Fan HC, Lin FC, Lin CL, Hsu YC.
ABSTRACT: Whether exposure to air pollution is associated with developing sensorineural hearing loss (SHL) 
remains controversial. Using data from the National Health Insurance Research Database, we recruited a total 
of 75,767 subjects aged older than 20 years with no history of SHL from 1998 to 2010, and they were followed 
up until SHL was observed, they withdrew from the National Health Insurance program, or the study ended. The 
subjects were evenly exposed to low-level, mid-level, and high-level carbon monoxide (CO) and nitrogen dioxide 
(NO2). The incidence rate ratio of SHL for patients exposed to high-level CO was 1.24 (95% confidence interval 
(CI) = 1.14-1.36). The NO2 pollutants increased the incidence rate ratios of SHL in mid-level NO2 and high-level 
NO2 exposures by 1.10 (95% CI = 1.10-1.32) and 1.36 (95% CI = 1.24-1.49) times, respectively. The adjusted 
hazard ratio (adj. HR) of SHL in patients exposed to high-level CO was 1.45 (95% CI = 1.31-1.59), relative to that 
of patients exposed to low-level CO. Compared to patients exposed to low-level NO2, patients exposed to mid-
level NO2 (adj. HR = 1.40, 95% CI = 1.27-1.54) and high-level NO2 (adj. HR = 1.63, 95% CI = 1.48-1.81) had a 
higher risk of developing SHL. The increased risk of SHL following the increased concentrations of air pollutants 
(CO and NO2) was statistically significant in this study. In conclusion, the subjects’ exposure to air pollution 
exhibited a significantly higher risk of developing SHL in Taiwan.
Mol Biol Rep. 2020 Apr 22. doi: 10.1007/s11033-020-05460-0. 
Mesenchymal stem cells for sensorineural hearing loss: a systematic review of preclinical studies.
Chorath K, Willis M, Morton-Gonzaba N, Moreira A.
ABSTRACT: Sensorineural hearing loss (SNHL) is the most common form of hearing loss that is routinely treated 
with hearing aids or cochlear implants. Advances in regenerative medicine have now led to animal studies 
examining the possibility of restoring injured hair cells with mesenchymal stem/stromal cell (MSC) administration. 
We conducted a systematic review and meta-analysis to collate the existing preclinical literature evaluating MSCs 
as a treatment for SNHL and quantify the effect of MSCs on functional hearing. Our protocol was published online 
on CAMARADES. Searches were conducted in four medical databases by two independent investigators. Twelve 
studies met inclusion and were evaluated for risk of bias using SYRCLE. Rodent models were commonly used 
(n = 8, 66%), while auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAE) 
were the most frequent measures assessing hearing loss. MSCs were derived from multiple tissue sources, 
including bone marrow, adipose tissue, and umbilical cord blood and the dose ranged from 4 × 103 to 1 × 107 
cells. Treatment with MSCs resulted in an improvement in ABR and DPOAE (mean difference-15.22, + 9.10, 
respectively). Despite high heterogeneity and multiple “unclear” domains in the risk of bias, this review provides 
evidence that MSCs may have a beneficial effect in hearing function.
Pediatr Infect Dis J. 2020 Apr;39(4):273-276. doi: 10.1097/INF.0000000000002564. 
Middle Ear Effusion in Children With Congenital Cytomegalovirus Infection.
Chung W, Leung J, Lanzieri TM, Blum P, Demmler-Harrison G, Ahmed S, Baer H, Bhatt AR, Brown 
F, Catlin F, Caviness AC, Coats DK, Edmonds JC, Flores M, Franklin D, Gandaria C, Greer J, 
Griesser C, Hussein MA, Iovino I, Istas A, Jin HD, Kelinske MK, Klingen JT, Laurente A, Littman T, 
Murphy M, Miller J, Nelson C, Noyola D, Paysse EA, Percy A, Reis S, Reynolds A, Rozelle J, Smith 
O, Steinkuller P, Turcich M, Vinson SS, Voigt RG, Walmus B, Williams J, Williamson D, Yen KG, Yow 
MD; Congenital Cytomegalovirus Longitudinal Study Group; Congenital Cytomegalovirus Longitudinal 
Study Group.
BACKGROUND: Sensorineural hearing loss (SNHL) is well described in children with congenital cytomegalovirus 
(CMV) infection, but limited data are available on middle ear effusion (MEE) occurrence in this population. We 
assessed the prevalence of MEE and the degree of transient hearing change associated with MEE among 
children with congenital CMV infection. 
METHODS: Children with congenital CMV infection enrolled in a longitudinal study received hearing and 
tympanometric testing during scheduled follow-up visits annually up to 6 years of age. We used a generalized 
linear mixed-effect logistic regression model to compare the odds of MEE, defined as type B tympanogram 
(normal ear canal volume with little tympanic membrane movement) among patients categorized as symptomatic 
or asymptomatic based on the presence of congenital CMV-associated signs in the newborn period. 
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RESULTS: Forty-four (61%) of 72 symptomatic and 24 (28%) of 87 asymptomatic patients had ≥1 visit with MEE. 
After controlling for the number of visits, symptomatic patients had significantly higher odds of MEE (odds ratio: 
2.09; 95% confidence interval: 1.39-3.14) than asymptomatic patients. Transient hearing decrease associated 
with a type B tympanogram ranged from 10 to 40 dB, as measured by audiometric air-bone gap in 11 patients. 
CONCLUSIONS: Among children with congenital CMV, MEE can result in transient hearing decrease, which can 
reduce the efficacy of a hearing aid in those with SNHL. It is warranted that children with congenital CMV infection 
and SNHL receive routine audiologic and tympanometric testing to better manage hearing aid amplification levels.
Otol Neurotol. 2019 Dec;40(10):1278-1286. doi: 10.1097/MAO.0000000000002410. 
Long-term Outcomes in Down Syndrome Children After Cochlear Implantation: Particular 
Issues and Considerations.
Clarós P, Remjasz A, Clarós-Pujol A, Pujol C, Clarós A, Wiatrow A.
OBJECTIVE: The aim of the study was to analyze the long-term outcomes after cochlear implantation in deaf 
children with Down syndrome (DS) regarding age at the first implantation and refer the results to preoperative 
radiological findings as well as postoperative auditory and speech performance. Additionally, the influence of the 
age at implantation and duration of CI use on postoperative hearing and language skills were closely analyzed in 
children with DS. 
STUDY DESIGN: Retrospective analysis. 
SETTING: Referral center (Cochlear Implant Center). 
MATERIALS AND METHODS: Nine children with Down syndrome were compared with 220 pediatric patients 
without additional mental disorders or genetic mutations. Patients were divided into four categories depending 
on the age of the first implantation: CAT1 (0-3 yr), CAT2 (4-5 yr), CAT3 (6-7 yr), and CAT4 (8-17 yr). The auditory 
performance was assessed with the meaningful auditory integration scales (MAIS) and categories of auditory 
performance (CAP) scales. The speech and language development were further evaluated with meaningful use 
of speech scale (MUSS) and speech intelligibility rating (SIR). The postoperative speech skills were analyzed and 
compared between the study group and the reference group by using nonparametric statistical tests. Anatomic 
abnormalities of the inner ear were examined using magnetic resonance imaging (MRI) and high-resolution 
computed tomography of the temporal bones (HRCT). 
RESULTS: The mean follow-up time was 14.9 years (range, 13.1-18.3 yr). Patients with DS received a 
multichannel implant at a mean age of 75.3 months (SD 27.9; ranging from 21 to 127 mo) and 220 non-
syndromic children from reference group at a mean age of 51.4 months (SD 34.2; ranging from 9 to 167 mo). 
The intraoperative neural response was present in all cases. The auditory and speech performance improved in 
each DS child. The postoperative mean CAP and SIR scores were 4.4 (SD 0.8) and 3.2 (SD 0.6), respectively. 
The average of scores in MUSS and MAIS/IT-MAIS scales was 59.8% (SD 0.1) and 76.9% (SD 0.1), respectively. 
Gathered data indicates that children with DS implanted with CI at a younger age (<6 years of age) benefited 
from the CI more than children implanted later in life, similarly in a control group. There were additional anomalies 
of the temporal bone, external, middle, or inner ear observed in 90% of DS children, basing on MRI or HRCT. 
CONCLUSIONS: The early cochlear implantation in children with DS is a similarly useful method in treating 
severe to profound sensorineural hearing loss (SNHL) as in non-syndromic patients, although the development 
of speech skills present differently. Due to a higher prevalence of ear and temporal bone malformations, detailed 
diagnostic imaging should be taken into account before the CI qualification. Better postoperative outcomes may 
be achieved through comprehensive care from parents/guardians and speech therapists thanks to intensive and 
systematic rehabilitation.
Eur J Radiol. 2020 Feb;123:108803. doi: 10.1016/j.ejrad.2019.108803. Epub 2019 Dec 26. 
Temporal bone and intracranial abnormalities in syndromic causes of hearing loss: an 
updated guide.
D’Arco F, Youssef A, Ioannidou E, Bisdas S, Pinelli L, Caro-Dominguez P, Nash R, Siddiqui A, Talenti G.
PURPOSE: To describe in detail the temporal bone and brain findings in both common and rare syndromic 
causes of hearing loss, with the purpose of broadening among radiologists and enhance the current 
understanding of distinct imaging features in paediatric patients with syndromic hearing loss. 
METHODS: A detailed search of electronic databases has been conducted, including PubMed, Ovid Medline, 
Scopus, Cochrane Library, Google Scholar, National Institute for Health and Care Excellence (NICE), Embase, 
and PsycINFO. 
RESULTS: Syndromic causes of hearing loss are characterised by different and sometimes specific abnormalities 
in the temporal bone. 
CONCLUSION: A complete knowledge of the image findings in the temporal bones, brain, skull and other body 
regions is critical for the optimal assessment and management of these patients.
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Int J Pediatr Otorhinolaryngol. 2020 Apr 10;134:110036. doi: 10.1016/j.ijporl.2020.110036. 
Nature and extent of hearing loss in HIV-infected children: A scoping review.
Dawood G, Klop D, Olivier E, Elliott H, Pillay M, Grimmer K.
INTRODUCTION: Antiretroviral therapy (ART) has had a major impact on life expectancy from HIV as many 
people now live with it as a chronic disease. Chronic HIV has been associated with a range of comorbid 
disabilities and health conditions, one of which is hearing loss. Undiagnosed and untreated hearing loss, 
particularly in children, has been linked to poorer spoken language skills, with subsequent effects on academic 
performance. 
METHODS: This systematic scoping review aimed to summarize the available peer-reviewed literature on 
hearing loss in HIV-infected children, specifically to describe its extent and nature. The review followed the 
framework proposed by Arksey and O’Malley. Key search terms included hearing loss (and synonyms), child 
(and synonyms), and HIV. Electronic databases (EBSCOhost Research Platform, PubMed, Web of Science and 
Scopus databases) were searched for any relevant articles published from January 1, 2000 to June 30, 2019. 
Reference lists of included articles were pearled for additional relevant articles not already identified. Each stage 
of the selection process was conducted independently by two authors. The results were then collated by a third 
author who also resolved any discrepancies. Extracted data included sample descriptors, audiologic tests, hearing 
loss prevalence, hearing loss descripts, and factors associated with hearing loss. 
RESULTS: Seventeen articles were included; 10 from Africa, four from South America, two from North America 
and the remaining article from Asia. Although most of the articles reported on pure tone audiometry, the samples 
as well as the cut-off criteria for normal hearing were heterogenous. Prevalence of hearing loss varied across 
articles (from 6% to 84%). Conductive hearing loss occurred more frequently than sensorineural or mixed hearing 
loss. ART use and ear infection were reported as significant in three of five articles that reported on significant 
associates of HIV-related hearing loss. 
CONCLUSION: There was a modest volume of research from a limited number of countries. Heterogeneity in 
sampling and audiometric methods precluded a clear understanding of potential associations between chronic 
HIV-related hearing loss and contributing factors.
Laryngoscope. 2020 Feb 17. doi: 10.1002/lary.28561. 
Cochlear Implantation in Children with Single-Sided Deafness.
Deep NL, Gordon SA, Shapiro WH, Waltzman SB, Roland JT Jr, Friedmann DR.
OBJECTIVE: To describe our experience with children undergoing unilateral cochlear implantation (CI) for 
treatment of single-sided deafness (SSD). 
STUDY DESIGN: Retrospective case series. 
METHODS: A retrospective case review from a tertiary referral center involving 14 pediatric patients (<18 years) 
with SSD who underwent unilateral CI. Speech perception testing in quiet and noise in the CI-only and bimodal 
conditions with at least 1 year of device use and device usage from data logs represent the main outcome 
measures. 
RESULTS: The mean age at CI was 5.0 years (median 4.4, range 1.0-11.8 years). The mean duration of deafness 
was 3.0 years (median 2.4, range 0.6-7.0 years). Mean follow-up was 3.4 years. Speech perception testing with 
a minimum of 1 year post-CI was available in eight patients. The mean word recognition scores (WRS) in the 
CI-only condition was 56%; a significant improvement from baseline. Testing in background noise with spatially 
separated speech and noise revealed that patients scored as well or better with the CI-on versus CI-off in all 
conditions and in no cases was interference from the CI noted. Data logs were reviewed for device usage which 
revealed an average use of 6.5 hr/d. 
CONCLUSION: Cochlear implantation is a viable treatment option for pediatric SSD in this self-selected cohort. 
Open-set speech and improvement in background noise can be achieved. Careful patient selection and thorough 
counseling on expectations is paramount to achieving successful outcomes.
JMIR Hum Factors. 2020 Mar 10. doi: 10.2196/16310. 
Usability of a Mobile App for Improving Literacy in Children with Hearing Impairment: A Focus 
Group Study.
DeForte S, Sezgin E, Huefner J, Lucius S, Luna J, Satyapriya AA, Malhotra P.
BACKGROUND: Children with hearing loss, even those identified early and who are using hearing aids or 
cochlear implants, may face challenges in developing spoken language and literacy. This can lead to academic, 
behavioral, and social difficulties. There are apps for healthy children to improve their spoken language and 
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literacy and apps that focus on sign language proficiency for children with hearing loss, but these apps are limited 
for children with hearing loss. We have therefore developed an app called Hear Me Read (HMR) which uses 
enhanced digital stories as therapy tools for speech, language, and literacy for children with hearing loss. The 
platform has therapist and parent/child modes that allows 1) selection of high quality, illustrated digital stories by a 
speech-language pathologist (SLP), parent, or child 2) modification of digital stories for a multitude of speech and 
language targets, and 3) assignment of stories by therapist to facilitate individualized speech and language goals. 
Additionally, HMR makes the caregiver a core partner in engagement through functionality whereby the caregiver 
can record video and audio of themselves to be played back by the child. 
OBJECTIVE: The objective of this study was to evaluate the user experience of the HMR app through a focus 
group study with caregivers and their children. 
METHODS: We recruited 16 participants (8 children with and without hearing loss and 8 caregivers) to participate 
in one-hour focus groups. Caregivers and children interacted with the app and discussed their experience through 
a semi-structured group interview. We employed thematic analysis methods and analyzed the data. We used 
feedback from the focus group to improve elements of the app for a larger clinical trial assessing the impact of the 
app on outcomes. 
RESULTS: We identified 3 themes: default needs, specific needs and family needs. Participants found the app 
to be aesthetically pleasing and easy to use. Findings helped us to identify usability attributes and to amend 
app functionalities to best fit user needs. Caregivers and children appreciated the enhancements, such as parts 
of speech highlighting and video playback of caregivers reading, that were made possible by the digital format. 
Participants expressed that the app could be used to enhance family reading sessions and family interaction. 
CONCLUSIONS: The findings from this focus group study are promising for the use of educational apps designed 
specifically for those with hearing loss who are pursuing listening and spoken language as a communication 
outcome. Further investigation is needed with larger sample sizes in order to understand the clinical impact on 
relevant language and literacy outcomes in this population.
J Pediatr. 2020 Mar;218:151-156.e2. doi: 10.1016/j.jpeds.2019.12.005. Epub 2020 Jan 14. 
A Cross-Sectional Study of Caregiver Perceptions of Congenital Cytomegalovirus Infection: 
Knowledge and Attitudes about Screening.
Diener ML, Shi K, Park AH.
OBJECTIVES: To understand caregiver knowledge of and attitudes toward congenital cytomegalovirus (cCMV) 
testing in Utah. 
STUDY DESIGN: We surveyed 365 caregivers whose children were being seen in an otolaryngology clinic at a 
tertiary pediatric hospital about their knowledge of and attitudes toward cCMV and cCMV screening. Descriptive 
statistics and cluster analysis were used to examine their responses. 
RESULTS: The majority of caregivers were unsure how cCMV was spread, the symptoms of cCMV, and why 
cCMV screening of infants was important. Most caregivers did not know that cCMV screening was required by law 
in Utah if an infant is referred after newborn hearing screening. A majority wanted to know if their child had cCMV 
even if asymptomatic and were willing to pay $20 for cCMV screening. Caregivers of children who had been 
tested for cCMV were significantly more likely to be strongly in favor of cCMV screening than expected by chance. 
Caregivers in the highly knowledgeable cluster were more likely to be strongly in favor of cCMV screening. 
CONCLUSIONS: Caregivers frequently were unaware of cCMV and its implications. Attitudes toward cCMV 
screening generally were positive. Education on epidemiology and impact of cCMV may benefit both prevention of 
infection and attitudes toward screening.
Eur J Pediatr. 2020 May;179(5):807-812. doi: 10.1007/s00431-019-03558-7. Epub 2020 Jan 11. 
Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study.
Dorfman L, Amir J, Attias J, Bilavsky E.
ABSTRACT: Recently, valganciclovir treatment of symptomatic congenital cytomegalovirus (cCMV) disease, 
commenced during the neonatal period (≤ 4 weeks), was found to improve hearing and developmental outcome. 
However, many children (symptomatic or asymptomatic at birth) present only after 4 weeks of age. The purpose 
of this observational retrospective study was to describe the outcome and safety of valganciclovir therapy in 
infants with cCMV who started treatment > 4 weeks of life. Of the 91children who started antiviral treatment 
> 4 weeks of age, 66/298 (22.2%) were symptomatic at birth; 25/217 (11.5%) were asymptomatic at birth. 
Treatment was initiated on average at 14 weeks of age (range 5-77 weeks) and at 53.3 weeks (range 12-
156 weeks), respectively. Of the 45 affected ears in the symptomatic group, 30 (66.7%) improved and only 2 
(4.4%) deteriorated, with most of the improved ears (27/30, 90%) returning to normal. In the asymptomatic group, 
late-onset treatment was initiated and out of the 42 deteriorated ears, 38 (90.5%) improved after at least 1 year of 
follow-up. Hematological adverse events, i.e., neutropenia, were noted in a minority of cases (4.4%).Conclusion: 
Our study demonstrates the benefits and safety aspects of treating symptomatic and asymptomatic children with 
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cCMV even beyond the recommended neonatal period.What is Known:• Valganciclovir treatment of symptomatic 
congenital cytomegalovirus (cCMV) disease, commenced during the neonatal period, is beneficial in improving 
hearing and developmental outcome.• However, data of treatment started beyond the neonatal period is lacking.
What is New:• Our study demonstrates the benefits of treating symptomatic children with cCMV as well as 
asymptomatic children that develop late-onset hearing loss even beyond the recommended neonatal period.• This 
was true for symptomatic children who presented > 4 weeks as well as to those were asymptomatic at birth but 
experienced late hearing deterioration.
Eur J Hum Genet. 2020 May;28(5):587-596. doi: 10.1038/s41431-019-0553-8. Epub 2019 Dec 12. 
Exome sequencing in infants with congenital hearing impairment: a population-based cohort 
study.
Downie L, Halliday J, Burt R, Lunke S, Lynch E, Martyn M, Poulakis Z, Gaff C, Sung V, Wake M, 
Hunter MF, Saunders K, Rose E, Lewis S, Jarmolowicz A, Phelan D, Rehm HL; Melbourne Genomics 
Health Alliance, Amor DJ.
ABSTRACT: Congenital hearing impairment (HI) is the most common sensory impairment and can be isolated or 
part of a syndrome. Diagnosis through newborn hearing screening and management through early intervention, 
hearing aids and cochlear implantation is well established in the Australian setting; however understanding 
the genetic basis of congenital HI has been missing. This population-derived cohort comprised infants with 
moderate-profound bilateral HI born in the 2016-2017 calendar years, detected through newborn hearing 
screening. Participants were recruited through an integrated paediatric, otolaryngology and genetics HI clinic 
and offered whole exome sequencing (WES) on a HiSeq4000 or NextSeq500 (Illumina) platform with a targeted 
average sequencing depth of 100x and chromosome microarray on the Illumina Infinium core exome-24v1.2 
platform. Of those approached, 68% (106/156) consented to participate. The rate of genetic diagnosis was 
56% (59/106), significantly higher than standard of care (GJB2/6 sequencing only), 21% (22/106). There were 
clinical implications for the 106 participants: 36% required no further screening, 9% had tailored screening 
initiated, 2% were offered treatment and 4% had informed care for a complex neurodevelopmental syndrome. 
WES in this cohort demonstrates the range of diagnoses associated with congenital HI and confirms the genetic 
heterogeneity of congenital HI. The high diagnostic yield and clinical implications emphasises the need for 
genomic sequencing to become standard of care.
Genet Med. 2020 Jan 24. doi: 10.1038/s41436-019-0745-1. 
Exome sequencing in newborns with congenital deafness as a model for genomic newborn 
screening: the Baby Beyond Hearing project.
Downie L, Halliday J, Lewis S, Lunke S, Lynch E, Martyn M, Gaff C, Jarmolowicz A, Amor DJ.
PURPOSE: Genomic newborn screening raises practical and ethical issues. Evidence is required to build a 
framework to introduce this technology safely and effectively. We investigated the choices made by a diverse 
group of parents with newborns when offered tiered genomic information from exome sequencing. 
METHODS: This population-derived cohort comprised infants with congenital deafness. Parents were offered 
exome sequencing and choice regarding the scope of analysis. Options were choice A, diagnostic analysis only; 
choice B, diagnostic analysis plus childhood-onset diseases with medical actionability; or choice C, diagnostic 
analysis plus childhood-onset diseases with or without medical actionability.
RESULTS: Of the 106 participants, 72 (68%) consented to receive additional findings with 29 (27.4%) selecting 
choice B and 43 (40.6%) opting for choice C. Family size, ethnicity, and age of infant at time of recruitment were 
the significant predictors of choice. Parents who opted to have additional findings analysis demonstrated less 
anxiety and decisional conflict. 
CONCLUSIONS: These data provide evidence from a culturally diverse population that choice around additional 
findings is important and the age of the infant when this choice is offered impacts on their decision. We found no 
evidence that offering different levels of genomic information to parents of newborns has a negative psychological 
impact.
Int J Pediatr Otorhinolaryngol. 2020 Apr;131:109864. doi: 10.1016/j.ijporl.2020.109864. Epub 2020 Jan 7. 
Comparison of ABR and ASSR using NB-chirp-stimuli in children with severe and profound 
hearing loss.
Eder K, Schuster ME, Polterauer D, Neuling M, Hoster E, Hempel JM, Semmelbauer S.
INTRODUCTION: Objective techniques for hearing threshold estimation in infants and children with profound or 
severe hearing loss play a key role in pediatric audiology to prevent speech acquisition disorders by choosing 
the adequate therapy. Auditory brainstem responses and auditory steady-state responses are available for 
frequency-dependent hearing threshold estimations and both techniques show strong correlations. However, 
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various systems and stimuli are available, which is one reason why comparison is challenging, and, so far, no 
single “gold standard” could be established for hearing threshold estimation in children suffering from profound or 
severe hearing loss. The aim of the study was to compare hearing threshold estimations in children with profound 
or severe hearing loss derived with narrow-band CE-chirps evoked auditory brainstem responses and auditory 
steady-state response.
SUBJECTS and METHODS: 71 children (121 ears) with an age from 3 month to 15 years were measured with 
the Interacoustics Eclipse EP25 ABR system® (Denmark) with narrow-band CE-chirps® at 500, 1000, 2000 and 
4000 Hz under identical conditions. 
RESULTS: Auditory brainstem responses and auditory steady-state responses highly correlate (r = 0.694, 
p < 0.001). Correlation coefficients differ depending on the center frequency and patient age. Generally, auditory 
steady-state responses show a better hearing threshold than auditory brainstem responses or a remaining 
hearing threshold when auditory brainstem responses could not be obtained. In approximately 15% of cases this 
would have affected the therapeutic strategy when only taking one technique into account. 
CONCLUSION: Auditory brainstem responses and auditory steady-state responses should be jointly used in the 
diagnostic approach in children with suspected profound or severe hearing loss.
Int J Pediatr Otorhinolaryngol. 2019 Dec;127:109681. doi: 10.1016/j.ijporl.2019.109681. Epub 2019 Sep 13. 
Evaluation and therapy outcome in children with auditory neuropathy spectrum disorder 
(ANSD).
Ehrmann-Müller D, Cebulla M, Rak K, Scheich M, Back D, Hagen R, Shehata-Dieler W.
OBJECTIVES: The aims of the present study are to: describe diagnostic findings in patients with auditory 
neuropathy spectrum disorder (ANSD); and demonstrate the outcomes of different therapies like hearing aids 
(HAs) or cochlear implantation. 
METHODS: 32 children were diagnosed and treated at our tertiary referral center and provided with HAs or 
cochlear implants (CIs). All of them underwent free-field or pure-tone audiometry. Additionally, otoacoustic 
emissions (OAEs), impedance measurements, auditory brainstem responses (ABRs), auditory steady-state 
responses (ASSR), electrocochleography, and cranial magnetic resonance imaging (cMRI) were all performed. 
Some patients also underwent genetic evaluation. Following suitable provision pediatric audiological tests, 
psychological developmental diagnostic and speech and language assessments were carried out at regular 
intervals in all the children. 
RESULTS: OAEs could initially be recorded in most of the children; 17 had no ABRs. The other eight children 
had a poor ABR morphology. Most of the children had typical, long-oscillating cochlear microphonics (CMs) in 
their ABRs, which was also observed in all of those who underwent electrocochleography. Eight children were 
provided with a HA and 17 received a CI. The functional gain was between 32 and 65 decibel (dB) with HAs and 
between 32 and 50 dB with CI. A speech discrimination level between 35 and 100% was achieved during open-set 
monosyllabic word tests in quiet with HA or CI. With the Hochmair-Schulz-Moser (HSM) sentence test at 65 dB 
SPL (sound pressure level), 75% of the children with a CI achieved a speech discrimination in noise score of at 
least 60% at a signal to noise ratio (SNR) of 5, and four scored 80% or higher. Most of the children (72%) were 
full-time users of their devices. All the children with a CI used it on a regular basis. 
CONCLUSION: Only a few case reports are available in the literature regarding the long-term outcomes of ANSD 
therapy. The present study reveals satisfactory outcomes with respect to hearing and speech discrimination in 
children with CIs or HAs. The nearly permanent use of the devices reflects a subjective benefit for the children. 
Provision with a suitable hearing device depends on audiological results, the speech and language development 
of an individual child, and any accompanying disorders. Repeated audiological evaluations, interdisciplinary 
diagnostics, and intensive hearing and speech therapy are essential for adequate rehabilitation of this group of 
children.
Blood Coagul Fibrinolysis. 2020 Apr 22. doi: 10.1097/MBC.0000000000000911. 
Thrombosis risk of Alport syndrome patients: evaluation of cardiological, clinical, 
biochemical, genetic and possible causes of inherited thrombophilia and identification of a 
novel COL4A3 variant.
Eroz R, Damar İH, Kılıçaslan O.
ABSTRACT: To evaluate cases with Alport syndrome for laboratory, radiological, ophthalmological, auditory 
tests, cardiological and inherited thrombophilia risk. Laboratory findings, abdominal and urinary ultrasonography, 
ophthalmological and auditory tests and cardiological examination of 21 Alport syndrome suspicious cases 
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were performed. Also, collagen type IV alpha three chain (COL4A3) gene, four chain (COL4A4) gene and five 
chain (COL4A5) genes were sequenced by next-generation sequencing system. In addition, possible causes 
of inherited thrombophilia were evaluated. A novel (c.2806C>T/p.Gln936Ter) variation in COL4A3 gene was 
detected in three cases. Also c.221G>A/p.Arg74Gln variation in COL4A5 gene of two cases, c.4421C>T/p.
Thr1474Met variation in COL4A4 gene of one case, c.665C>T/p.Pro222Leu variation in COL4A4 gene of one 
case and compound heterozygous c.4421C>T/(p.Thr1474Met) and c.665C>T/p.Pro222Leu variation in COL4A4 
gene of one case were detected. Although 10 (47.6%) cases had microscopic hematuria, six (28.6%) cases 
had macroscopic hematuria, but there were not hematuria in five (23.8%) of cases. Three cases with variation 
carrier in COL4A genes and one case without variation carrier had vision problem. Also, one case with variation 
carrier in COL4A gene had hearing loss. All cases with variation carrier in COL4A genes exclude one had at least 
one cardiac problems. Also, all cases with variation carrier in COL4A genes had possible causes of inherited 
thrombophilia risk. In addition to developing risk of progressive kidney failure, sensorineural hearing loss and 
ocular abnormalities, Alport syndrome cases may have increasing cardiac problems and possible causes of 
inherited thrombophilia risk. Therefore, these cases should be regularly evaluated and followed for cardiac 
problems and inherited thrombophilia risk.
World J Pediatr. 2020 Jan 7. doi: 10.1007/s12519-019-00325-4. 
Etiology of newborn hearing impairment in Guangdong province: 10-year experience with 
screening, diagnosis, and follow-up.
Fang BX, Cen JT, Yuan T, Yin GD, Gu J, Zhang SQ, Li ZC, Liang YF, Zeng XL.
BACKGROUND: Hearing impairment is one of the most common birth defects in children. Universal newborn 
hearing screenings have been performed for 19 years in Guangdong province, China. A screening/diagnosis/
intervention system has gradually been put in place. Over the past 10 years, a relatively complete data 
management system had been established. In the present study, an etiological analysis of newborn cases that 
failed the initial and follow-up screenings was performed. 
METHODS: The nature and degree of hearing impairment in newborns were confirmed by a set of procedures 
performed at the time of initial hearing screening, rescreening and final hearing diagnosis. Then, multiple 
examinations were performed to explore the associated etiology. 
RESULTS: Over a period of 10 years, 720 children were diagnosed with newborn hearing loss. Among these 
children, 445 (61.81%) children had a clearly identified cause, which included genetic factor(s) (30.56%), 
secretory otitis media (13.30%), maternal rubella virus infection during pregnancy (5.83%), inner ear 
malformations (4.86%), maternal human cytomegalovirus infection during pregnancy (2.92%), malformation of 
the middle ear ossicular chain (2.50%) and auditory neuropathy (1.81%). In addition, 275 cases of sensorineural 
hearing loss of unknown etiology accounted for 38.19% of the children surveyed. 
CONCLUSIONS: Long-term follow-up is needed to detect delayed hearing impairment and auditory development 
in children. The need for long-term follow-up should be taken into account when designing an intervention 
strategy. Furthermore, the use of the deafness gene chip should further elucidate the etiology of neonatal hearing 
impairment.
Am J Audiol. 2019 Dec 16;28(4):1025-1045. doi: 10.1044/2019_AJA-19-0061. Epub 2019 Dec 12. 
Candidacy for Amplification in Children With Hearing Loss: A Review of Guidelines and 
Recommendations.
Fitzpatrick EM, Cologrosso E, Sikora L.
PURPOSE: The 1st point in the intervention process for the majority of children is the fitting of hearing devices. 
The objective of this review was to compile guidelines and recommendations for candidacy criteria for children 
with hearing loss. 
METHOD: Electronic databases (e.g., MEDLINE, Embase, and Cumulative Index of Nursing and Allied Health 
Literature) and websites were searched. Any document referring to children with hearing loss that discussed 
amplification guidelines or protocols was included. Documents specific to implantable devices or addressing 
only remote microphone systems were excluded. One reviewer screened all potentially relevant documents, 
and a subset was screened by a 2nd reviewer. Guidelines/recommendations referring to pediatric amplification 
candidacy were extracted. 
RESULTS: A total of 40 documents were included for data extraction. Studies were categorized according to 
hearing loss of any degree, with separate categories for documents providing specific criteria for mild bilateral, 
unilateral, and auditory neuropathy spectrum disorders. Guidelines ranged from generic statements about 
the need for amplification to criteria based on specific audiometric thresholds. In guidelines recommending 
audiometric cut-points, the majority considered > 25 dB HL as a criterion for consideration for amplification. 
Overall, guidelines for children with mild bilateral and unilateral loss remain more ambiguous, and there was some 
variation across the recommendations. Guidelines for auditory neuropathy spectrum disorder stressed the need to 
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obtain results from behavioral audiometry before considering amplification. 
CONCLUSIONS: Numerous organizations have established candidacy guidelines for pediatric amplification. Most 
guidelines specify criteria for amplification as audiometric threshold levels. There is considerable variation in the 
guidelines for mild bilateral and unilateral hearing loss with candidacy criteria ranging from 15 to 30 dB HL, and 
many guidelines recommend a case-by-case decision approach.
Int J Pediatr Otorhinolaryngol. 2020 Feb 27;133:109975. doi: 10.1016/j.ijporl.2020.109975. 
Impact of Universal Newborn Hearing Screening on cochlear implanted children in Ireland.
Gabriel MM, Geyer L, McHugh C, Thapa J, Glynn F, Walshe P, Simoes-Franklin C, Viani L.
OBJECTIVES: Cochlear Implant (CI) is an established treatment for severe to profound hearing loss (HL). Early 
diagnosis and intervention in HL are crucial in order to provide access to sound and increase the likelihood of 
spoken language development in pre-lingually deaf children. In April 2011, the Health Service Executive (HSE) 
implemented the Universal Newborn Hearing Screening (UNHS) in a phased regional basis in Ireland. This study 
aimed to investigate the general clinical pathway for UNHS referrals to the CI service and to evaluate the impact 
of earlier referrals via UNHS on functional outcomes in children. 
METHODS: The first part of this study constituted a retrospective review of 100 children referred to the National 
Hearing Implant and Research Centre (NHIRC) via UNHS from November 2011 to December 2016. Implanted 
children referred via UNHS were categorised into three groups according to their medical status. Their clinical 
pathway to cochlear implantation was evaluated. Functional outcomes were investigated based on medical and 
developmental status, respectively. In the second part of this study, developmentally healthy implanted children 
referred post-UNHS were compared with medically healthy children referred pre-UNHS under the age of four, 
from January 2005 to June 2011. Current implant status of children, age at referral and functional outcomes were 
investigated. 
RESULTS: Medically healthy children were referred to the NHIRC at an earlier age than the medically complex 
children (2.8 months vs 5.2 months, p < 0.01) and the children presenting with auditory neuropathy spectrum 
disorder (ANSD) (2.8 months vs 5.3 months, p < 0.01). On average they attended their first appointment and were 
implanted at a younger age than the ANSD group (6.1 months vs 10.1 months, p < 0.01; 16.3 months vs 29.4 
months, p < 0.001, respectively). Developmentally healthy children had significantly better functional outcomes 
than children with developmental delays. Children referred via UNHS were referred and implanted at a younger 
age than those referred pre-UNHS. The former group achieved better Categories of Auditory Performance (CAP) 
and Speech Intelligibility Rating (SIR) scores 2 years post-implantation. 
CONCLUSION: UNHS in Ireland is an important platform for earlier diagnosis and management of congenital HL 
and our results show that early intervention has a positive impact on functional outcomes in children.
J Clin Microbiol. 2020 Mar 25;58(4). pii: e01951-19. doi: 10.1128/JCM.01951-19. Print 2020 Mar 25. 
Performance of the Alethia CMV Assay for Detection of Cytomegalovirus by Use of Neonatal 
Saliva Swabs.
Gantt S, Goldfarb DM, Park A, Rawlinson W, Boppana SB, Lazzarotto T, Mertz LM.
ABSTRACT: Congenital cytomegalovirus (cCMV) infection is a major cause of childhood hearing loss and 
neurodevelopmental delay. Identification of newborns with cCMV infection allows provision of beneficial 
interventions. However, most infants with cCMV infection have subclinical infection and go undiagnosed. Thus, 
expanded neonatal CMV testing is increasingly recommended. Saliva is an attractive sample type for CMV testing 
of newborns, because it is easier to collect than urine and more sensitive for CMV detection than dried blood 
spots. We evaluated the Alethia CMV assay, a rapid, easy-to-use loop-mediated isothermal amplification method 
for qualitative detection of CMV DNA in neonatal saliva samples. Saliva swabs were collected prospectively from 
newborns <21 days old and tested by the Alethia assay according to the manufacturer’s instructions. Archived 
saliva swabs from newborns with cCMV infection were also tested retrospectively. A composite reference method 
(CRM; two validated PCR assays followed by bidirectional sequencing of amplicons) was performed on all 
samples as the reference standard comparator. Of 1,480 prospectively collected saliva swabs, 1,472 (99.5%) 
were negative by both the Alethia assay and CRM, 5 (0.34%) were positive by both the Alethia assay and CRM, 
and 3 (0.20%) were positive only by the Alethia assay. All 34 (100%) archived swabs from newborns with cCMV 
infection were positive by both the CRM and the Alethia assay. Overall, the Alethia assay showed 100% and 
99.8% positive and negative agreement with the CRM, respectively. The Alethia CMV assay is an accurate 
method for identifying neonates with cCMV infection and, given its simplicity, appears suitable for CMV testing 
using neonatal saliva outside a reference laboratory, including remote and resource-limited settings.
Copyright © 2020 American Society for Microbiology.
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Medicine (Baltimore). 2020 Mar;99(13):e19373. doi: 10.1097/MD.0000000000019373. 
Screening for mitochondrial 12S rRNA C1494T mutation in 655 patients with non-syndromic 
hearing loss: An observational study.
Gao Z, Yuan YS.
ABSTRACT: Mutations in mitochondrial DNA, especially in 12S rRNA gene, are the most important causes 
for hearing loss. In particular, the A1555G and C1494T mutations have been found to be associated with both 
aminoglycoside-induced and non-syndromic hearing loss in many families worldwide. To determine the frequency 
of C1494T mutation in deaf patients, in the current study, we screened this mutation in 655 patients with non-
syndromic hearing loss and 300 control subjects. After PCR amplification of mitochondrial 12S rRNA gene and 
direct sequence analysis, we found that there were 2 patients carrying the C1494T mutation; however, this 
mutation was not detected in 300 healthy subjects. Further genetic counseling suggested that only 1 patient 
had an obvious family history of hearing impairment. Clinical evaluation showed that 3 of 10 matrilineal relatives 
suffered from hearing loss, with different age at onset of hearing loss. Molecular analysis revealed the presence 
of homoplasmic 12S rRNA C1494T and ND5 T12338C mutations, together with a set of polymorphisms belonging 
to human mitochondrial haplogroup F2. Interestingly, T12338C mutation resulted in the replacement of the first 
amino acid, a translation-initiating methionine with a threonine, shortening 2 amino acids of ND5 polypeptide. 
Moreover, this mutation is located in 2 nucleotides adjacent to the 3’ end of the mt-tRNALeu(CUN) gene. 
Therefore, this mutation may alter ND5 mRNA metabolism and the processing of RNA precursors. Thus, the 
combination of T12338C and C1494T mutations may contribute to deafness expression in this family. Taken 
together, our data suggested that the C1494T mutation was the molecular basis for hearing loss, screening for 
the mitochondrial DNA pathogenic mutations was recommended for early detection, prevention, and diagnosis of 
mitochondrial deafness.
J Perinatol. 2020 May;40(5):774-780. doi: 10.1038/s41372-020-0628-y. Epub 2020 Feb 26. 
Treatment for hypotension in the first 24 postnatal hours and the risk of hearing loss among 
extremely low birth weight infants.
Gogcu S, Washburn L, O’Shea TM.
OBJECTIVE: To evaluate whether treated hypotension in the first 24 postnatal hours is associated with hearing 
loss in extremely low birth weight (ELBW) infants. 
STUDY DESIGN: In a cohort of 735 ELBW infants, we identified 25 with sensorineural hearing loss (SNHL) at 
12-24 months adjusted age. For each case, we selected three controls with normal hearing. Logistic regression 
models were used to adjust for confounding variables. 
RESULTS: Sixty percent of cases and 25% of controls were treated for hypotension. After adjusting for 
confounding variables (gestational age, antenatal glucocorticoids, 5 min Apgar < 6, insertion of an umbilical 
catheter, treatment with high frequency ventilation, and major cranial ultrasound abnormality), treated hypotension 
was associated with an increased risk of SNHL (adjusted odds ratio: 3.6; 95% confidence interval: 1.3-9.7). 
CONCLUSIONS: Treated hypotension in ELBW infants in the first 24 h of life is associated with an increased risk of SNHL.
Cureus. 2020 Jan 4;12(1):e6566. doi: 10.7759/cureus.6566. 
Prevalence of Sensorineural Hearing Loss in Children with Palliated or Repaired Congenital 
Heart Disease.
Gopineti L, Paulpillai M, Rosenquist A, Van Bergen AH.
BACKGROUND: Children with congenital heart disease (CHD) are at increased risk of neurodevelopmental 
deficits, and the presence of sensorineural hearing loss (SNHL) may further lead to poor language skills 
acquisition and speech delays. Prevalence of SNHL in the general pediatric population is estimated to be 0.2% at 
birth to 0.35% during adolescence. Very few studies have attempted to estimate SNHL prevalence in children who 
have undergone congenital heart surgery. 
METHODS: This retrospective study aimed to estimate SNHL prevalence in children who underwent congenital 
heart surgery in our institution and were followed up in our high-risk pediatric cardiology clinics for four years 
from 2009 to 2013. Data were collected on demographics, preoperative variables, surgical variables, and post-
operative variables. 
RESULTS: SNHL prevalence in asymptomatic, palliated/repaired CHD patients followed in our high-risk clinics 
and undergoing routine surveillance was 11.6% (20 of 172 patients with hearing impairment). SNHL prevalence 
was not statistically higher in single-ventricle patients (17.2%) compared to biventricular patients (14.7%). 
Inotropic score in the first 24 hours of postoperative period (p=0.05), lowest arterial PaO2 (p=0.003), duration 
of Lasix drip (p=0), and bolus dose in days (p=0.03) were all found to be statistically significant in the hearing-
impaired group. However, using logistic regression, we identified no statistically significant predictors for hearing 
loss. 
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CONCLUSION: The results suggest the need for routine audiology screening of all patients with complex CHD, 
especially those who have undergone neonatal cardiac repair/palliation at less than one year of age, irrespective 
of risk factors.
Hum Genet. 2020 Apr;139(4):521-530. doi: 10.1007/s00439-020-02118-6. Epub 2020 Jan 30. 
Concurrent hearing and genetic screening in a general newborn population.
Guo L, Xiang J, Sun L, Yan X, Yang J, Wu H, Guo K, Peng J, Xie X, Yin Y, Wang J, Yang H, Shen J, 
Zhao L, Peng Z.
ABSTRACT: Newborn hearing screening is not designed to detect delayed-onset prelingual hearing loss or 
aminoglycoside-antibiotic-induced ototoxicity. Cases with severe to profound hearing loss have been reported 
to have been missed by newborn hearing screens. The aim of this study was to evaluate the efficacy of 
concurrent hearing and genetic screening in the general population and demonstrate its benefits in practice. 
Enrolled newborns received concurrent hearing and genetic screens between September 1, 2015 and January 
31, 2018. Of the 239,636 eligible infants (median age, 19 months), 548 (0.23%) had prelingual hearing loss. 
Genetic screening identified 14 hearing loss patients with positive genotypes and 27 patients with inconclusive 
genotypes who had passed the hearing screens. In addition, the genetic screen identified 0.23% (570/239,636) 
of the newborns and their family members as at-risk for ototoxicity, which is undetectable by hearing screens. In 
conclusion, genetic screening complements newborn hearing screening by improving the detection of infants at 
risk of hereditary hearing loss and ototoxicity, and by informing genotype-based clinical management for affected 
infants and their family members. Our findings suggest that the practice should be further validated in other 
populations and rigorous cost-effectiveness analyses are warranted.
Laryngorhinootologie. 2020 Mar 4. doi: 10.1055/a-1114-6452. [Article in German]
Evaluation of Universal Newborn Hearing Screening and follow-up.
Hall V, Brosch S, Hoffmann TK.
BACKGROUND: Universal newborn hearing screening (UNHS) was established in Germany in 2009. Even 
compliance was tested in early studies, there is little knowledge regarding the follow-up examination of children 
with suspected hearing disorder. 
METHODS: A retrospective evaluation was performed in 570 cases of children who failed newborn hearing 
screening for the years between 2009-2016. Hearing deficiency was defined as having a hearing threshold 
≥ 35 dB. Compliance with national guidelines was checked. Every child received brainstem evoked response 
audiometry (BERA). 
RESULTS: Permanent hearing disorder was found in 24 %, of whom about half (51 %) had an inner ear 
hearing loss (of these in 73 % bilateral). Only 27 % of high risk children born in peripheral hospitals were tested 
immediately by the envisaged automated auditory brainstem response (AABR) method. They often presented 
tardy, leading to a delayed diagnosis and therapy. Children tracked by the Bavarian health office presented little 
earlier but had less cases who were lost to follow-up. 
DISCUSSION: In 93 % a diagnosis was made during first examination and therapy (e. g. prescription of hearing 
aids) initiated on average within four months age. The rate of deafness corresponded with national averages. The 
quality of primary screenings is crucial in revealing problems and avoiding delay in dealing with them.
J Neurooncol. 2020 Jan;146(1):147-156. doi: 10.1007/s11060-019-03356-z. Epub 2019 Nov 28. 
Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors 
of pediatric embryonal brain tumor.
Heitzer AM, Villagran AM, Raghubar K, Brown AL, Camet ML, Ris MD, Hanning JH, Okcu MF, Paulino 
AC, Chintagumpala M, Kahalley LS.
PURPOSE: Survivors of pediatric embryonal brain tumors (BT) are at high risk for sensorineural hearing loss 
(SNHL) associated with neurocognitive decline. However, previous studies have not assessed the relationship 
between SNHL and adaptive functioning. We examined neurocognitive and adaptive functioning in patients with 
and without SNHL. 
METHODS: Participants included 36 patients treated for an embryonal BT with craniospinal irradiation (CSI) 
and cisplatin chemotherapy who were assessed 6.7 years post-treatment on average. The impact of SNHL on 
neurocognitive performance and parent-rated adaptive functioning was assessed in univariate and multivariate 
analyses. 
RESULTS: There were 17 cases with SNHL (mean age at evaluation = 14.4) and 19 cases with NH (mean age 
at evaluation = 13.8). After accounting for age at diagnosis and additional covariates in multivariable analyses, 
SNHL was associated with worse overall intellectual functioning (p = 0.027) and perceptual reasoning (p = 0.016) 
performance. There was no effect of SNHL on adaptive functioning in multivariable models. Age at diagnosis and 
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sex were associated with performance on neurocognitive measures. 
CONCLUSIONS: SNHL in pediatric embryonal BT is associated with increased risk for neurocognitive deficits in 
conjunction with other demographic and treatment-related factors.
Cleft Palate Craniofac J. 2019 Dec 23:1055665619895635. doi: 10.1177/1055665619895635. 
Eustachian Tube Dysfunction in Children With Unilateral Cleft Lip and Palate: Differences 
Between Ipsilateral and Contralateral Ears.
Hu A, Shaffer AD, Jabbour N.
OBJECTIVE: To evaluate Eustachian tube dysfunction in the ipsilateral and contralateral ears, in children with 
unilateral cleft lip and palate (UCLP). 
DESIGN: Retrospective chart review. 
SETTING: Tertiary care children’s hospital. 
PATIENTS: Seventy-four consecutive patients with UCLP born between 2005 and 2011 and treated at UPMC 
Children’s Hospital of Pittsburgh Cleft-Craniofacial Center were included. 
MAIN OUTCOME MEASURES: Conductive hearing loss, tympanogram type, number of middle ear effusions, 
tympanostomy tubes, and complications. Hypothesis was formulated prior to data collection. 
RESULTS: Conductive hearing loss was nearly twice as common in the ipsilateral ear (43.2%) compared with 
contralateral (23.0%; P = .001, McNemar test). There were no significant differences in the frequency of each 
type of tympanogram between the contralateral and ipsilateral ears. The proportions of ipsilateral (90.5%) and 
contralateral (91.9%) ears with effusion were not significantly different. The total number of tubes received was 
not significantly different between the 2 ears (median of 2 bilaterally). When combined, complications (retractions, 
perforations, and cholesteatomas) were significantly more common in the ipsilateral ear (29.7%) compared with 
the contralateral ear (18.9%; P = .039, McNemar test). 
CONCLUSION: In children with UCLP, there were significantly more instances of conductive hearing loss and 
complications on the cleft side compared to the noncleft side. This suggests that Eustachian tube dysfunction 
may indeed be more severe on the cleft side. Considering this information, clinicians may need to be especially 
observant of the ipsilateral ear.
Am J Audiol. 2020 Mar 5;29(1):23-34. doi: 10.1044/2019_AJA-19-00054. Epub 2020 Jan 14. 
Auditory Detection Thresholds and Cochlear Resistivity Differ Between Pediatric Cochlear 
Implant Listeners With Enlarged Vestibular Aqueduct and Those With Connexin-26 Mutations.
Jahn KN, Bergan MD, Arenberg JG.
PURPOSE: The goal of this study was to evaluate differences in the electrode-neuron interface as a function 
of hearing loss etiology in pediatric cochlear implant (CI) listeners with enlarged vestibular aqueduct (EVA) 
syndrome and in those with autosomal recessive connexin-26 mutations (DFNB1). 
METHOD: Fifteen implanted ears (9 participants, 5 ears with EVA, 10 ears with DFNB1) were assessed. Single-
channel auditory detection thresholds were measured using broad and spatially focused electrode configurations 
(steered quadrupolar; focusing coefficients = 0 and 0.9). Cochlear resistivity estimates were obtained via 
electrode impedances and electrical field imaging. Between-group differences were evaluated using linear mixed-
effects models. 
RESULTS: Children with EVA had significantly higher auditory detection thresholds than children with DFNB1, 
irrespective of electrode configuration. Between-group differences in thresholds were more pronounced on apical 
electrodes than on basal electrodes. In the apex, electrode impedances and electrical field imaging values were 
higher for children with EVA than for those with DFNB1. 
CONCLUSIONS: The electrode-neuron interface differs between pediatric CI listeners with DFNB1 and those 
with EVA. It is possible that optimal clinical interventions may depend, in part, on hearing loss etiology. Future 
investigations with large samples should investigate individualized CI programming strategies for listeners with 
EVA and DFNB1.
Iran J Otorhinolaryngol. 2020 Mar;32(109):85-92. doi: 10.22038/ijorl.2019.36090.2191. 
Prevalence of Hearing Loss among School-Age Children in the North of Iran.
Jalali MM, Nezamdoust F, Ramezani H, Pastadast M.
INTRODUCTION: The present study aimed to investigate the audiological profiles of elementary school-age 
children in Rasht, Iran, and estimate the prevalence of hearing impairments in this population. 
MATERIALS AND METHODS: In this cross-sectional descriptive-analytical study, the hearing threshold was 
screened using pure tone audiometry (PTA). Hearing impairment was defined as equal to or higher than 20 dB 
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HL. Results of the hearing thresholds were separately reported in the left or right ears and better or worse ears. 
Logistic regression tests were used to investigate the association between hearing loss and possible risk factors. 
In this study, all the analyses were conducted using SPSS software (version 21). 
RESULTS: The present study was carried out on a total of 2019 children. Mean age of the participants was 
reported as 9.66±1.66 years. Based on low-frequency pure-tone average, the prevalence rates of hearing loss > 
15 dB in the right and left ears were reported as 1.94% and 1.68%, respectively. The high-frequency hearing loss 
> 15 dB in the right and left ears was obtained at 1.14% and 1.04%, respectively. Prevalence rate of hearing loss 
(in all frequencies) in boys was higher than that in girls. There was a strong association between a history of otitis 
media and sensorineural or conductive hearing loss (adjusted odds ratio reported as 12.2 and 8.1, respectively). 
CONCLUSION: In this study, the rate of hearing loss in the participants was approximately 2%. It was concluded 
that the screening of hearing loss in children is necessary for the identification and management of these children 
as early as possible. It is recommended to perform further trials to investigate the impact of different causes on 
childhood hearing impairment.
J Infect Dis. 2020 Mar 5;221(Supplement_1):S9-S14. doi: 10.1093/infdis/jiz446. 
Congenital Cytomegalovirus Infection.
Kabani N, Ross SA.
ABSTRACT: Congenital cytomegalovirus (cCMV) infection is a leading cause of hearing loss and neurological 
disabilities in children, with the disease burden and disabilities due to cCMV greater than many other well 
recognized childhood conditions. A minority of infants with cCMV will have symptoms at birth. Infants with 
symptomatic cCMV are at higher risk for sequelae than those born without symptoms. The majority of infants 
with cCMV are asymptomatic at birth, but 10%-15% will develop hearing loss. Although clinical symptoms can 
help predict which infants will have sensorineural hearing loss, among asymptomatic cCMV there are currently 
no predictors of adverse outcome. The identification of a biomarker to identify those at highest risk of sequelae 
is highly desirable to target interventions to those who could potentially benefit. Because there is increasing 
rationale for establishing both targeted and universal screening programs for cCMV in the United States and 
worldwide, this is an urgent priority.
Lancet Infect Dis. 2020 Feb;20(2):220-229. doi: 10.1016/S1473-3099(19)30416-5. Epub 2019 Nov 7. 
Congenital viral infections in England over five decades: a population-based observational 
study.
Kadambari S, Pollard AJ, Goldacre MJ, Goldacre R.
BACKGROUND: Congenital viral infections cause substantial long-term morbidity but population-based data 
about diagnosis rates are scarce. The aim of this study was to assess the long-term trends in congenital viral 
infections in England and to report on how the rates of these infections might have changed with improved 
methods for detection, the introduction of the two-dose measles-mumps-rubella (MMR) vaccine in 1996, and the 
implementation of the Newborn Hearing Screening Programme (NHSP) in 2006. 
METHODS: For this population-based, observational cohort study, we used national and regional hospitalisation 
data from 1968 to 2016 in England (Hospital In-Patient Enquiry, Hospital Episode Statistics, and Oxford Record 
Linkage Study) to calculate annual rates of hospital discharges coded with-and individuals aged younger than 1 
month diagnosed with-congenital cytomegalovirus, herpes simplex virus (HSV), varicella zoster virus (VZV), and 
rubella. We investigated associations of congenital cytomegalovirus, HSV, and VZV with perinatal and maternal 
factors (sex, mother’s ethnicity, mode of delivery, gestational age, birthweight, mother’s age, mother’s index of 
multiple deprivation, and number of previous pregnancies). 
FINDINGS: In 2016, discharge rates per 100 000 infant population were 22·3 (95% CI 18·8-26·1) for congenital 
cytomegalovirus, 17·6 (14·6-21·1) for HSV, 32·6 (28·4-37·2) for VZV, and 0·15 (0·0-0·8) for rubella. Compared 
with earlier years of the study, the discharge rate in 2016 was higher for congenital cytomegalovirus, HSV, and 
VZV, whereas it was lower for rubella. For congenital cytomegalovirus, there was a significant step-increase 
between 2006 and 2007 following implementation of the NHSP (rate ratio comparing the trend line post-NHSP 
with that pre-NHSP 1·55 [95% CI 1·12-2·14], p=0·0072). Congenital cytomegalovirus infection was associated 
with birthweight less than 1 kg, maternal age younger than 25 years, socioeconomically deprived households, 
casearean section, and mothers of black ethnicity. Congenital HSV infection was associated with maternal age 
younger than 20 years, gestational age less than 32 weeks, and vaginal and emergency caesarean section 
deliveries, while VZV infection was associated with increased parity and black and south Asian ethnicities. 
INTERPRETATION: The increase in hospital discharges coded with congenital cytomegalovirus is most likely 
due to the introduction of sensitive diagnostic techniques and retrospective diagnoses made in infants after 
implementation of the NHSP. Public health strategies to improve prevention and treatment of congenital viral 
infections are urgently warranted. The decrease in discharges for rubella is most likely due to the MMR vaccine.
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Laryngoscope. 2020 Jan;130(1):212-216. doi: 10.1002/lary.27722. Epub 2018 Dec 8. 
Clinical Guidelines in Pediatric Hearing Loss: Systemic Review Using the Appraisal of 
Guidelines for Research and Evaluation II Instrument.
Kanabur P, Hubbard C, Jeyakumar A.
OBJECTIVES: Despite the importance, impact, and prevalence of pediatric hearing loss (HL), there are very few 
published clinical practice guidelines (CPG) supporting the evaluation and management of pediatric patients with 
HL. Our objective was to appraise existing CPGs to ensure safe and effective practices. 
METHODS: A literature search was conducted in PubMed, Google Scholar, EBSCO, as well as a manual Google 
search. Three independent assessors using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) instrument evaluated CPGs related to HL in children. Standardized domain scores were calculated for each 
guideline. 
RESULTS: A total of four guidelines met the inclusion criteria and were appraised. Scope and purpose achieved 
a high median score of 83%. Stakeholder involvement, clarity of presentation, and editorial independence 
achieved intermediate scores of 67%, 54%, and 50%, respectively. The areas that required most improvement 
and achieved low scores were rigor of development and applicability, with scores of 22% and 38%, respectively. 
Based on the AGREE II measures, the four guidelines had domain scores less than 60% for each domain, and 
without modification no guideline could be recommended. 
CONCLUSIONS: Based on the AGREE II, the qualities of CPGs for pediatric HL have several shortcomings, 
and the need for a comprehensive CPG remains. Rigor of development and applicability present the greatest 
opportunities for improvement of these CPGs. 
J Turk Ger Gynecol Assoc. 2020 Jan 13. doi: 10.4274/jtgga.galenos.2019.2019.0070. 
Does Antenatal Magnesium Sulphate improve hearing function in premature newborns?
Kasapoğlu I, Çetinkaya Demir B, Atalay MA, Orhan A, Özkan H, Çakır SC, Tütüncü Toker R, 
Kasapoğlu F, Özerkan K.
OBJECTIVE: To evaluate whether antenatal magnesium sulphate (MgSO4) exposure has a neuroprotective 
effect against hearing impairment in premature newborns. 
MATERIALS AND METHODS: Retrospective cohort study performed with prematurely (<37 weeks) delivered 
newborns at a tertiary university hospital. Newborns of 92 women who received MgSO4 infusions (study group) 
for various indications were compared to newborns of 147 women who did not receive MgSO4 infusions (control 
group). Every eligible premature newborn underwent hearing screening by auditory brainstem response (ABR) 
testing before being discharged from the hospital. 
RESULTS: The fail rate in ABR hearing screening was 3.3% (n=3) in the study group and 10.9% (n=16) in the 
control group (p=0.034). The rate of concurrent use of betamethasone was higher in the study group (72.8%; 
n= 67) compared to control group (29.2%; n=43) (p<0.001). Other neonatal parameters such as the number 
of neonates who are small for gestational age and the rate of microcephaly were similar between the groups 
(p=0.54, p=0.48, respectively). After adjusting for co-variates including the use of betamethasone and gestational 
age at delivery, we did not find any statistically significant association between antenatal administration of MgSO4 
and fail rates in hearing screening by ABR testing (p=0.07). 
CONCLUSION: Our results do not suggest a clear and definite benefit from antenatal MgSO4 infusion in respect 
of hearing impairment in premature newborns.
Int J Environ Res Public Health. 2020 Apr 10;17(7). pii: E2613. doi: 10.3390/ijerph17072613. 
What Are the Current Audiological Practices for Ototoxicity Assessment and Management in 
the South African Healthcare Context?
Khoza-Shangase K, Masondo N.
ABSTRACT: The study was an initial exploration of the current ototoxicity assessment and management 
practices by audiologists in South Africa. An exploratory survey research methodology through a cross-sectional 
research design was adopted where audiologists were recruited from professional associations’ databases in 
South Africa, using specific inclusion criteria. The study made use of an 18-item web-based survey guided by 
the Health Professions Council of South Africa (HPCSA) (2018) guidelines which were developed from reviewing 
international guidelines such as the American Speech-Language-Hearing Association (ASHA,1994) and the 
American Academy of Audiology (AAA, 2009). The study surveyed 31 audiologists from across the country. Data 
were analyzed through descriptive statistics. Findings implied significant gaps between knowledge and translation 
of this knowledge into practice. Over two thirds of the participants engage with ototoxicity monitoring and 
management, but the practices adopted by them do not align with international standards nor with the national 
HPCSA guidelines on assessment and management of patients on ototoxic medications. Most participants do not 
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conduct baseline assessments, and the frequency of monitoring is irregular and reduced from the recommended; 
thus influencing ability for early detection and intervention of ototoxicity within this context. Non-standard 
assessment battery is used for assessment and monitoring, raising questions about the reliability and validity of 
the data used to make preventive treatment decisions. Lack of collaborative work between audiologists and the 
rest of the clinical team involved in the treatment of patients on ototoxic medications was found to be an important 
contributing factor to the less than optimal ototoxicity management practices. Of factors potentially influencing 
adherence to guidelines, the institution of employment, specifically employment in a tuberculosis hospital, 
seemed to have a positive influence, possibly due to the focused nature of the audiologists’ scope of practice 
there as well as availability of resources. The level of education appeared to have no influence. Current findings 
provide contextually relevant evidence on ototoxicity assessment and management within this context. They raise 
important implications for guidelines adherence and translating knowledge, policies and guidelines into practice, 
clinical assessment and management protocols followed, appropriate resource allocation per programme, as 
well as strategic planning for national ototoxicity assessment and management programmes in context. The 
findings also raise important implications for low- and middle-income countries, in terms of adopting international 
guidelines without considering context.
Genet Med. 2020 Mar 17. doi: 10.1038/s41436-020-0774-9. 
Significant Mendelian genetic contribution to pediatric mild-to-moderate hearing loss and its 
comprehensive diagnostic approach.
Kim BJ, Oh DY, Han JH, Oh J, Kim MY, Park HR, Seok J, Cho SD, Lee SY, Kim Y, Carandang M, 
Kwon IS, Lee S, Jang JH, Choung YH, Lee S, Lee H, Hwang SM, Choi BY.
PURPOSE: Timely diagnosis and identification of etiology of pediatric mild-to-moderate sensorineural hearing 
loss (SNHL) are both medically and socioeconomically important. However, the exact etiologic spectrum remains 
uncertain. We aimed to establish a genetic etiological spectrum, including copy-number variations (CNVs) and 
efficient genetic testing pipeline, of this defect. 
METHODS: A cohort of prospectively recruited pediatric patients with mild-to-moderate nonsyndromic SNHL from 
2014 through 2018 (n = 110) was established. Exome sequencing, multiplex ligation-dependent probe amplification 
(MLPA), and nested customized polymerase chain reaction (PCR) for exclusion of a pseudogene, STRCP, from a 
subset (n = 83) of the cohort, were performed. Semen analysis was also performed to determine infertility (n = 2). 
RESULTS: Genetic etiology was confirmed in nearly two-thirds (52/83 = 62.7%) of subjects, with STRC-
related deafness (n = 29, 34.9%) being the most prevalent, followed by MPZL2-related deafness (n = 9, 
10.8%). This strikingly high proportion of Mendelian genetic contribution was due particularly to the frequent 
detection of CNVs involving STRC in one-third (27/83) of our subjects. We also questioned the association of 
homozygous continuous gene deletion of STRC and CATSPER2 with deafness-infertility syndrome (MIM61102). 
CONCLUSION: Approximately two-thirds of sporadic pediatric mild-to-moderate SNHL have a clear Mendelian 
genetic etiology, and one-third is associated with CNVs involving STRC. Based on this, we propose a new 
guideline for molecular diagnosis of these children.
Clin Exp Otorhinolaryngol. 2020 Jan 14. doi: 10.21053/ceo.2019.01144. 
A Retrospective Review of Temporal Bone Computed Tomography to Present Safe Guideline 
for Bone-Anchored Hearing Aids.
Kim S, Cho YS, Cho YS, Moon IJ.
OBJECTIVES: Bone-anchored hearing device (BAHD) is contraindicated in patients younger than 5 years 
because their calvarial bones are not thick enough to be implanted site. However, it has not been studied in the 
Korean population. This study was not only to establish a safe guideline for depth of implant device in all age 
groups who undergo BAHD implant surgery, but also to investigate whether implantation of currently used BAHDs 
could be done safely in Korean children, especially those younger than 5. 
METHODS: Two hundred eighty patients, who underwent high-resolution temporal bone computed tomography 
(TBCT) images between August 2010 and October 2018 were randomly enrolled in all ages. We retrospectively 
reviewed TBCT imaging to measure skull bone thickness at the recommended BAHD implant site. 
RESULTS: The average skull bone thickness was 2.87 mm in patients younger than 5 years and 6.72 mm in 
patients older than 5 years, respectively, which conforms to the current guideline. The results indicate nearly 50% 
of calvarial bone thicknesses were less than 3 mm in patients under 5 years old, while 92.78% of the patients 
older than 5 years of age showed bone thickness greater than 4 mm. Of note, calvarial bone thickness was 
thicker than 3 mm in all patients who are older than 6 years.
CONCLUSION: This study confirms that the currently approved BAHD implantation guideline is suitable in the 
Korean population. For safety, we suggest taking TBCTs prior to surgery, especially in pediatric patients. Besides, 
noninvasive applications are recommended for patients younger than 5.
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Int Arch Otorhinolaryngol. 2020 Apr;24(2):e198-e205. doi: 10.1055/s-0039-1698775. Epub 2020 Jan 28. 
An Investigation of Hearing (250-20,000 Hz) in Children with Endocrine Diseases and 
Evaluation of Tinnitus and Vertigo Symptoms.
Kocyigit M, Bezgin SU, Cakabay T, Ortekin SG, Yıldız M, Ozkaya G, Aydın B.
INTRODUCTION: Despite much advancement in medicine, endocrine and metabolic diseases remain an 
important cause of morbidity and even mortality in children. 
OBJECTIVE: The present study was planned to investigate the evaluation of hearing that also includes high 
frequencies, and the presence and degree of vertigo and tinnitus symptoms in pediatric patients diagnosed with 
endocrine diseases such as type 1 diabetes mellitus (DM), growth hormone deficiency (GHD), obesity, idiopathic 
short stature, and precocious puberty 
METHODS: The present study included a patient group of 207 children patients diagnosed with endocrine 
disease (95 males, 112 females; mean age 9.71 years old [range 6-16 years old]) and a control group including 
55 healthy children who do not have any kind of chronic disease (26 males, 29 females; mean age 9.33 years old 
[range 6-16 years old]). The subjects underwent a hearing test with frequencies between 250 and 20,000 Hz. The 
vestibular and tinnitus symptoms were evaluated with the Pediatric Vestibular Symptom Questionnaire. 
RESULTS: Out of 207 patients in the patient group, 5 (2.4%) had hearing loss in pure tones, 10 (4.8%) had it in 
high frequencies, 40 (19.3%) had tinnitus symptoms, and 18 (8.7%) had vertigo symptoms. A total of 4 out of 207 
patients in the study group (1.9%), 2 out of 59 with type 1 DM patients (3.4%), 1 out of 46 with GHD (2.2%), and 1 
out of 43 obesity patients (2.3%) had hearing loss, vertigo, and tinnitus symptoms. 
CONCLUSIONS: Our results suggest that some childhood endocrine diseases can cause some changes in the 
inner ear, although the exact cause is unknown. Perhaps, a detailed hearing and balance examination should be 
a routine in a child diagnosed with an endocrine disease. We think it is necessary to work on more comprehensive 
patient groups and tests in the future.
Int J Pediatr Otorhinolaryngol. 2020 Feb 3;132:109926. doi: 10.1016/j.ijporl.2020.109926. 
Limitations and drawbacks of the hospital-based universal neonatal hearing screening 
program: First report from the Arabian Peninsula and insights.
Kolethekkat AA, Al Abri R, Hlaiwah O, Al Harasi Z, Al Omrani A, Sulaiman AA, Al Bahlani H, Al Jaradi 
M, Mathew J.
OBJECTIVES: To assess the efficacy of the current universal neonatal hearing screening program in a tertiary 
medical institution in Oman, identify its limitations and drawbacks, and explore their causative factors. 
METHODS: A retrospective review was carried out to analyse the hearing screening of 12,743 live babies born 
between January 2016 and December 2018. Screen coverage, drop outs, follow up rate, and age at completion 
of screening, diagnosis, and intervention were analysed. The results were compared with the Joint Committee on 
Infant Hearing (JCIH) performance quality indices. Prospective questionnaire-based telephonic interviews were 
then conducted with the parents or caregivers of neonates with hearing loss. Finally, the causes of loss to follow 
up or delays in hearing screenings, diagnosis, and/or early intervention were studied. 
RESULTS: The true prevalence of hearing loss was 4.0 in 1000. The coverage of first-stage screening was 90% 
whereas the compliance with the second stage was 88.04%. 22.8% of the patients eventually obtained final 
diagnostic confirmation. The overall compliance with amplification was 30.2%. The completion ages of primary 
screening and final confirmation were 7.98 and 17.3 weeks respectively. The importance of hearing screening 
is well received by parents, but problems related to communication, delays in the appointment system, and 
inefficient follow up tracking were identified as the main limitations and drawbacks of the program. 
CONCLUSION: The coverage of the neonatal hearing screening program had not yet reached the required goal 
of 95%. The performance indicators also fell below the international benchmark. There is a need to address 
the identified causative factors. Effective communication and well-maintained tracking systems need to be 
implemented.
Int J Pediatr Otorhinolaryngol. 2020 Jan 28;132:109906. doi: 10.1016/j.ijporl.2020.109906. 
The efficacy of bone-anchored hearing implant surgery in children: A systematic review.
Kruyt IJ, Bakkum KHE, Caspers CJI, Hol MKS.
OBJECTIVE: To evaluate the efficacy of Bone-Anchored Hearing implants (BAHIs) in children and to elucidate 
the usage and outcomes of new surgical techniques and implants in this specific population. DATA SOURCES: 
Embase and PubMed. 
STUDY SELECTION: We identified studies evaluating surgical outcomes of BAHIs in children. Retrieved articles 
were screened using predefined inclusion and exclusion criteria. Critical appraisal included directness of evidence 
and risk of bias. Studies that successfully passed critical appraisal were included.
DATA EXTRACTION: Outcome measures included patient demographics, follow-up time, surgical technique 
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(one-versus two-stage surgery), tissue handling technique (reduction versus preservation), type of implant used, 
and complications. 
DATA SYNTHESIS: We selected 20 articles published between 2000 and 2017 for data extraction, encompassing 
952 implanted BAHIs. The overall mean age at implantation was 8.6 years (range, 2-21 years). Adverse soft-
tissue reactions occurred in 251 of the 952 implants (26.4%; range 0%-89% across studies). Revision surgery 
was performed in 16.8% (142 of the 845) of the implants. The total rate of implant loss, i.e. caused by OIF 
(n = 61), trauma (n = 33), recurrent infection (n = 15), elective removal due to insufficient benefit (n = 1), cosmetic 
reasons (n = 1), or unknown reason (n = 16), was 13.3% of the implants (127 out of 952; range 0%-40% across 
studies). Differences are seen in the type of implants used; wide-diameter implants seem to be superior in 
terms of implant survival, and similar in terms of adverse skin reactions, while one-stage surgery and soft-tissue 
preservation do not seem to result in higher implant loss rates or increased adverse skin reactions based upon 
limited amounts of literature. 
CONCLUSION: In general, BAHIs are a safe method for hearing rehabilitation in children, although large 
differences between studies are observed. The outcomes of new surgical techniques and implant designs in the 
pediatric population seem promising, but more research is needed before definitive conclusions can be drawn.
Front Pediatr. 2020 Jan 31;8:13. doi: 10.3389/fped.2020.00013. eCollection 2020. 
Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and 
Management From a Panel of European Experts.
Lazzarotto T, Blázquez-Gamero D, Delforge ML, Foulon I, Luck S, Modrow S, Leruez-Ville M.
ABSTRACT: Maternal primary and non-primary cytomegalovirus (CMV) infection during pregnancy can result in 
in utero transmission to the developing fetus. Congenital CMV (cCMV) can result in significant morbidity, mortality 
or long-term sequelae, including sensorineural hearing loss, the most common sequela. As a leading cause of 
congenital infections worldwide, cCMV infection meets many of the criteria for screening. However, currently there 
are no universal programs that offer maternal or neonatal screening to identify infected mothers and infants, no 
vaccines to prevent infection, and no efficacious and safe therapies available for the treatment of maternal or fetal 
CMV infection. Data has shown that there are several maternal and neonatal screening strategies, and diagnostic 
methodologies, that allow the identification of those at risk of developing sequelae and adequately detect cCMV. 
Nevertheless, many questions remain unanswered in this field. Well-designed clinical trials to address several 
facets of CMV treatment (in pregnant women, CMV-infected fetuses and both symptomatic and asymptomatic 
neonates and children) are required. Prevention (vaccines), biology and transmission factors associated with non-
primary CMV, and the cost-effectiveness of universal screening, all demand further exploration to fully realize the 
ultimate goal of preventing cCMV. In the meantime, prevention of primary infection during pregnancy should be 
championed to all by means of hygiene education.
Value Health. 2020 Feb;23(2):164-170. doi: 10.1016/j.jval.2019.07.019. Epub 2019 Oct 10. 
Health-Related Quality of Life in Children With Low Language or Congenital Hearing Loss, as 
Measured by the PedsQL and Health Utility Index Mark 3.
Le HND, Petersen S, Mensah F, Gold L, Wake M, Reilly S.
OBJECTIVES: To examine health-related quality of life (HRQoL) in young children with low language or 
congenital hearing loss and to explore 
the value of assessing HRQoL by concurrently administering 2 HRQoL instruments in populations of children. 
METHODS: Data were from 2 Australian community-based studies: Language for Learning (children with typical 
and low language at age 4 years, n = 1012) and the Statewide Comparison of Outcomes study (children with 
hearing loss, n = 108). HRQoL was measured using the parent-reported Health Utilities Index Mark 3 (HUI3) 
and the Pediatrics Quality of Life Inventory 4.0 (PedsQL) generic core scale. Agreement between the HRQoL 
instruments was assessed using intraclass correlation and Bland-Altman plots. 
RESULTS: Children with low language and with hearing loss had lower HRQoL than children with normal 
language; the worst HRQoL was experienced by children with both. The lower HRQoL was mainly due to impaired 
school functioning (PedsQL) and speech and cognition (HUI3). Children with hearing loss also had impaired 
physical and social functioning (PedsQL), vision, hearing, dexterity, and ambulation (HUI3). Correlations between 
instruments were poor to moderate, with low agreement. 
CONCLUSIONS: Children with low language and congenital hearing loss might benefit from interventions 
targeting overall health and well-being, not just their impairments. The HUI3 and PedsQL each seemed to provide 
unique information and thus may supplement each other in assessing HRQoL of young children, including those 
with low language or congenital hearing loss.
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Am J Obstet Gynecol. 2020 Feb 24. pii: S0002-9378(20)30198-8. doi: 10.1016/j.ajog.2020.02.018.
Cytomegalovirus infection during pregnancy: state of the science.
Leruez-Ville M, Foulon I, Pass R, Ville Y.
ABSTRACT: Cytomegalovirus is the most common congenital infection, affecting 0.5-2% of all live births and 
the main nongenetic cause of congenital sensorineural hearing loss and neurological damage. Congenital 
cytomegalovirus can follow maternal primary infection or nonprimary infection. Sensorineurological morbidity is 
confined to the first trimester with up to 40-50% of infected neonates developing sequelae after first-trimester 
primary infection. Serological testing before 14 weeks is critical to identify primary infection within 3 months 
around conception but is not informative in women already immune before pregnancy. In Europe and the United 
States, primary infection in the first trimester are mainly seen in young parous women with a previous child 
younger than 3 years. Congenital cytomegalovirus should be evoked on prenatal ultrasound when the fetus is 
small for gestation and shows echogenic bowel, effusions, or any cerebral anomaly. Although the sensitivity of 
routine ultrasound in predicting neonatal symptoms is around 25%, serial targeted ultrasound and magnetic 
resonance imaging of known infected fetuses show greater than 95% sensitivity for brain anomalies. Fetal 
diagnosis is done by amniocentesis from 17 weeks. Prevention consists of both parents avoiding contact with 
body fluids from infected individuals, especially toddlers, from before conception until 14 weeks. Candidate 
vaccines failed to provide more than 75% protection for >2 years in preventing cytomegalovirus infection. 
Medical therapies such as cytomegalovirus hyperimmune globulins aim to reduce the risk of vertical transmission 
but 2 randomized controlled trials have not found any benefit. Valaciclovir given from the diagnosis of primary 
infection up to amniocentesis decreased vertical transmission rates from 29.8% to 11.1% in the treatment group 
in a randomized controlled trial of 90 pregnant women. In a phase II open-label trial, oral valaciclovir (8 g/d) 
given to pregnant women with a mildly symptomatic fetus was associated with a higher chance of delivering 
an asymptomatic neonate (82%), compared with an untreated historical cohort (43%). Valganciclovir given to 
symptomatic neonates is likely to improve hearing and neurological symptoms, the extent of which and the 
duration of treatment are still debated. In conclusion, congenital cytomegalovirus infection is a public health 
challenge. In view of recent knowledge on diagnosis and pre- and postnatal management, health care providers 
should reevaluate screening programs in early pregnancy and at birth.
Lang Speech Hear Serv Sch. 2020 Jan 8;51(1):98-102. doi: 10.1044/2019_LSHSS-19-00075. Epub 2020 Jan 8. 
Where Do We Go From Here? Some Messages to Take Forward Regarding Children With Mild 
Bilateral and Unilateral Hearing Loss.
Lewis DE.
ABSTRACT: This epilogue discusses messages that we can take forward from the articles in the forum. A 
common theme throughout the forum is the ongoing need for research. The forum begins with evidence of 
potential progressive hearing loss in infants with mild bilateral hearing loss, who may be missed by current 
newborn hearing screening protocols, and supports the need for consensus regarding early identification in this 
population. Consensus regarding management similarly is a continuing need. Three studies add to the growing 
body of evidence that children with mild bilateral or unilateral hearing loss are at risk for difficulties in speech 
understanding in adverse environments, as well as delays in language and cognition, and that difficulties may 
persist beyond early childhood. Ambivalence regarding if and when children with mild bilateral or unilateral 
hearing loss should be fitted with personal amplification also impacts management decisions. Two articles 
address current evidence and support the need for further research into factors influencing decisions regarding 
amplification in these populations. A third article examines new criteria to determine hearing aid candidacy in 
children with mild hearing loss. The final contribution in this forum discusses listening-related fatigue in children 
with unilateral hearing loss. The absence of research specific to this population is evidence for the need for 
further investigation. Ongoing research that addresses difficulties experienced by children with mild bilateral and 
unilateral hearing loss and potential management options can help guide us toward interventions that are specific 
for the needs of these children.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Dec 7;54(12):881-887. doi: 10.3760/cma.j.is
sn.1673-0860.2019.12.001. [Article in Chinese]
A follow-up study of abnormal mutation in neonatal deafness gene screening.
Liu QM, Tian Y, Yu JJ, He QQ, Peng L, Guo XQ, Li DY, Chen T.
OBJECTIVE: To screen, diagnose and follow up the abnormal mutation in the gene screening of neonatal deafness. 
METHODS: A total of 24161 newborns born in Zhuhai Maternal and Child Health Hospital from February 1, 2015 
to January 31, 2008 were screened for hearing and deafness genes, and audiological screening, diagnosis and 
1-3 years follow-up were carried out for the newborns with positive gene screening. 
RESULTS: There were 991 cases of deafness gene mutation (533 males and 458 females), and the rate of 
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abnormal mutation was 4.10%(991/24 161). Among them, 921 cases were single heterozygous mutation, 130 
cases were failed in primary hearing screening, 11 cases were failed in secondary hearing screening, 8 cases 
were abnormal in audiological diagnosis finally. In these 8 cases, 3 were diagnosed as otitis media and passed 
audiological follow-up after cure, 2 cases of single ear sensorineural injury caused by high-risk factors, passed 
after close audiological follow-up, and the other 3 cases were closely audiological follow-up while none of 
them were successfully sequenced. All of them were moderate to severe sensorineural deafness, 1 case was 
heterozygous mutation at 3 loci of GJB2(c.235delC,c.408C>A,c.134G>A), 1 case was heterozygous mutation at 
2 loci of GJB2(c.235delC, c.109G>A), and 1 case was single heterozygous mutation of GJB2(c.235delC). The 
remaining 913 cases who passed the primary screening, secondary screening or hearing diagnosis were followed 
up for 1 to 3 years. Three cases of multiple heterozygous mutation were found in gene screening(2 cases were 
SLC26A4 2168A>G, IVS7-2A>G, 1 case was GJB2 c.176_191del 16bp, c.299_300del AT), all of them passed 
both primary and secondary hearing screening. In these 3 cases, the final audiological diagnosis was moderate 
sensorineural deafness in both ears, with no improvement in the follow-up of 1-3 years. There were 9 monogenic 
homozygous mutations, 7 failed in primary hearing screening, 3 failed in secondary hearing screening and 
also failed in audiological diagnosis and 1-3 years’ audiological follow-up, all of whom were GJB2 c.235 del C 
homozygous mutations, and one of whom had a definite family history of deafness. The remaining 6 cases of 
homozygous mutation diagnosed by primary screening, secondary screening or hearing diagnosis were GJB2 
c109G>A homozygous mutation, and passed the 1-3 years’ hearing follow-up. 58 children with mtDNA mutations, 
including 2 with 12S rRNA 1494C>T homozygous mutation, 47 with 1555A>G homozygous mutation, and 9 with 
1555A>G heterozygous mutation, all passed the primary or secondary hearing screening, and were instructed to 
ban ototoxic drugs for the whole life, and passed the 1-3 years’ hearing follow-up. 
CONCLUSIONS: The audiological follow-up of children with monogenic heterozygous mutations in deafness 
gene screening is generally normal. In case of abnormality, the influencing factors such as otitis media should be 
excluded at first. In case of unexplained moderate to severe sensorineural deafness, the whole-gene sequencing 
should be performed to find possible pathogenic factors. The children with homozygous mutation or compound 
heterozygous mutation in gene screening, most of whom show different degrees of hearing loss, should be 
followed up for a long time, and provide parents with scientific and reasonable genetic counseling according to 
the mutation genes and loci,. The hearing of drug-induced deafness gene carriers is normal after birth. Parents 
should be advised to strengthen prevention and follow-up is generally enough.
Int J Pediatr Otorhinolaryngol. 2020 Mar 12;133:109999. doi: 10.1016/j.ijporl.2020.109999. 
Implementation of auricular malformation screenings in the newborn population.
Liu YC, Kini S, Barton G, Pham T, Marcet-Gonzalez J, Novak B.
BACKGROUND AND OBJECTIVE: Research has shown that it is important to initiate ear molding early for children 
with auricular malformations in order to achieve the best results. Currently our institute relies on the traditional 
primary care physician (PCP) referral system, which does not recognize the time sensitivity of the visit in patients with 
auricular malformations. The purpose of the current research is to implement a new screening protocol for identifying 
auricular malformations in the newborn population and thus expedite the clinic visit and necessary intervention. 
METHODS: The hearing screen technicians (HSTs) were trained to identify some of the most common auricular 
malformations. A picture guide of 11 types of auricular malformations were given to the HSTs to use as a reference. 
At the time of the newborn hearing screen, the HSTs examined the pinnas of each baby. When an auricular 
malformation was identified, the auricular malformation team was immediately alerted and a bedside consultation with 
ENT occurred. 
RESULTS: Comparison was made of the referral rate between pre- and post-implementation of the protocol which 
showed an increased rate of identification (five referrals in the 12-month period pre-implementation versus eighteen 
referrals in the 15-month period post-implementation). 
CONCLUSION: We successfully implemented an auricular malformation screening protocol that was linked to 
newborn hearing screenings. The frequency of identification has increased with the implementation of the new 
screening protocol and has resulted in earlier initial ENT consultations for ear molding with the goal of improving 
patient satisfaction and results.
Cleft Palate Craniofac J. 2020 Feb 4:1055665619899743. doi: 10.1177/1055665619899743. 
Parental Judgement of Hearing Loss in Infants With Cleft Palate.
McAndrew L.
OBJECTIVE: To investigate whether reported parental concern is supported by hearing assessment findings in 
children with cleft palate. To describe this population by examining the relationship between cleft type, middle ear 
status, and hearing loss. 
DESIGN: Retrospective consecutive case note review. 
SETTING: Tertiary institutional regional cleft center. 
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PATIENTS: Consecutive cases of 194 babies born with cleft palate and referred to the specialist center from 
January 2009 and December 2013. Following exclusions, data from 155 infants were included for analysis. 
INTERVENTIONS: Documented parental concern in ear, nose and throat (ENT) and speech and language 
therapy case notes were compared to hearing assessment findings. Findings from otoscopic examination, 
tympanometry, and hearing assessment were analyzed with respect to cleft type. 
RESULTS: Parental concern is not always accurately reflected by objective assessment particularly when no 
concern is reported. Analysis of the cohort examined suggests that cleft type is not related to middle ear findings 
or hearing. 
CONCLUSIONS: It is helpful to be aware of parental concern and clinicians should consider that parental reports 
may not be accurately reflected by test results. As cleft type was not found to substantially influence middle ear 
status or hearing it is not recommended to adapt speech and language advice offered to families according to 
cleft type. Follow-up studies to increase participant numbers would support a statistical analysis.
Ear Hear. 2020 Feb 12. doi: 10.1097/AUD.0000000000000829. [Epub ahead of print] 
Prelinguistic Vocal Development in Children With Cochlear Implants: A Systematic Review.
McDaniel J, Gifford RH.
OBJECTIVES: This systematic review is designed to (a) describe measures used to quantify vocal development 
in pediatric cochlear implant (CI) users, (b) synthesize the evidence on prelinguistic vocal development in young 
children before and after cochlear implantation, and (c) analyze the application of the current evidence for 
evaluating change in vocal development before and after cochlear implantation for young children. Investigations 
of prelinguistic vocal development after cochlear implantation are only beginning to uncover the expected 
course of prelinguistic vocal development in children with CIs and what factors influence that course, which 
varies substantially across pediatric CI users. A deeper understanding of prelinguistic vocal development will 
improve professionals’ abilities to determine whether a child with a CI is exhibiting sufficient progress soon after 
implantation and to adjust intervention as needed. 
DESIGN: We systematically searched PubMed, ProQuest, and CINAHL databases for primary reports of children 
who received a CI before 5 years 0 months of age that included at least one measure of nonword, nonvegetative 
vocalizations. We also completed supplementary searches. 
RESULTS: Of the 1916 identified records, 59 met inclusion criteria. The included records included 1125 total 
participants, which came from 36 unique samples. Records included a median of 8 participants and rarely 
included children with disabilities other than hearing loss. Nearly all of the records met criteria for level 3 
for quality of evidence on a scale of 1 (highest) to 4 (lowest). Records utilized a wide variety of vocalization 
measures but often incorporated features related to canonical babbling. The limited evidence from pediatric CI 
candidates before implantation suggests that they are likely to exhibit deficits in canonical syllables, a critical vocal 
development skill, and phonetic inventory size. Following cochlear implantation, multiple studies report similar 
patterns of growth, but faster rates producing canonical syllables in children with CIs than peers with comparable 
durations of robust hearing. However, caution is warranted because these demonstrated vocal development 
skills still occur at older chronological ages for children with CIs than chronological age peers with typical hearing. 
CONCLUSIONS: Despite including a relatively large number of records, the evidence in this review regarding 
changes in vocal development before and after cochlear implantation in young children remains limited. A deeper 
understanding of when prelinguistic skills are expected to develop, factors that explain deviation from that 
course, and the long-term impacts of variations in vocal prelinguistic development is needed. The diverse and 
dynamic nature of the relatively small population of pediatric CI users as well as relatively new vocal development 
measures present challenges for documenting and predicting vocal development in pediatric CI users before 
and after cochlear implantation. Synthesizing results across multiple institutions and completing rigorous studies 
with theoretically motivated, falsifiable research questions will address a number of challenges for understanding 
prelinguistic vocal development in children with CIs and its relations with other current and future skills. Clinical 
implications include the need to measure prelinguistic vocalizations regularly and systematically to inform 
intervention planning.
Int J Pediatr Otorhinolaryngol. 2020 Jan 22;132:109900. doi: 10.1016/j.ijporl.2020.109900. 
Adherence to follow-up recommendations for babies at risk for pediatric hearing loss.
McInerney M, Scheperle R, Zeitlin W, Bodkin K, Uhl B.
OBJECTIVE: The purpose of this retrospective study was to evaluate the families’ compliance with 
recommendations for continued monitoring of babies with high-risk factors for hearing loss. 
METHODS: Hearing screening and follow-up results from 604 babies were tracked across a five-year period. 
Bivariate analysis, including chi-square analysis, t-tests, and one-way analyses of variance were conducted to test 
whether various factors predicted likelihood of follow up. 
RESULTS: Although 86% of the babies returned for the initial follow-up appointment, few completed the protocol 
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or were diagnosed with hearing loss (10.3%). Excluding the babies who never returned, the average age for initial 
assessment was near the recommended 3-month target (3.5 months). However, babies were last seen at 9.4 
months on average, which is earlier than recommended. Some factors positively predicted follow-up: receipt of 
ototoxic medication, hyperbilirubinemia requiring transfusion, ECMO, syndromes associated with hearing loss, 
craniofacial anomalies, and passing the newborn hearing screening. Others were negatively predictive: NICU stay 
>5 days, younger maternal age, and failing the newborn screening. There was no relationship between the results 
of the last test and whether the families continued with monitoring. Babies with risks categorized as more likely to 
be associated with delayed onset hearing loss were more often late to the initial follow up, but also followed up for 
a longer period of time. 
CONCLUSIONS: These results demonstrate the need to focus on the barriers unique to babies with risk factors 
for late onset/progressive hearing loss in addition to those barriers that generally affect loss to follow up. Tools for 
parental engagement are recommended.
Am J Audiol. 2019 Dec 16;28(4):823-833. doi: 10.1044/2019_AJA-19-0047. Epub 2019 Nov 5. 
Using Visual Supports to Facilitate Audiological Testing for Children With Autism Spectrum 
Disorder.
McTee HM, Mood D, Fredrickson T, Thrasher A, Bonino AY.
PURPOSE: One in 59 children is diagnosed with autism spectrum disorder (ASD). Due to overlapping symptoms 
between hearing loss and ASD, children who are suspected of having ASD require an audiological evaluation to 
determine their hearing status for the purpose of differential diagnosis. The purpose of this article is twofold: (a) 
to increase audiologists’ knowledge of ASD by discussing the challenges associated with testing and interpreting 
clinical data for children with ASD or suspected ASD and (b) to provide visual supports that can be used to 
facilitate audiological assessment. 
METHOD: Eight children (ages 4-12 years) were recruited as video model participants. Videos were filmed using 
scripts that used concise and concrete language while portraying common clinical procedures. Using the video 
models, corresponding visual schedules were also created. 
CONCLUSION: Although obtaining reliable hearing data from children with ASD is challenging, incorporating 
visual supports may facilitate testing. Video models and visual schedules have been created and made 
freely available for download online under a Creative Commons License (Creative Commons-Attribution-
NonCommercial-ShareAlike 4.0 International License). Incorporating visual supports during clinical testing has 
the potential to reduce the child’s and family’s stress, as well as to increase the probability of obtaining a reliable 
and comprehensive audiological evaluation. Future research is warranted to determine the effectiveness and 
feasibility of implementing these tools in audiology clinics. 
Gait Posture. 2020 Mar;77:144-155. doi: 10.1016/j.gaitpost.2020.02.001. Epub 2020 Feb 3. 
Does the practice of sports or recreational activities improve the balance and gait of children 
and adolescents with sensorineural hearing loss? A systematic review.
Melo RS, Tavares-Netto AR, Delgado A, Wiesiolek CC, Ferraz KM, Belian RB.
BACKGROUND: Balance and gait disorders have been observed in children and adolescents with sensorineural 
hearing loss (SNHL), justified by vestibular dysfunctions that these children may present, due to the injury to the 
inner ear. Therefore, some investigations have suggested that the practice of sports or recreational activities can 
improve the balance and gait of this population. 
OBJECTIVE: Assess the evidence quality from randomized or quasi-randomized controlled trials that used sports or 
recreational activities as an intervention to improve the balance and /or gait of children and/or adolescents with SNHL. 
METHODS: Systematic review that surveyed articles in nine databases, published up to January 10, 2019, in 
any language, using the following inclusion criteria: (1) Randomized or quasi-randomized controlled trials. (2) 
Participants from both groups with the clinical diagnosis of SNHL, aged 6-19 years old, without physical problems, 
cognitive or neurological deficits, except the vestibular dysfunction. (3) Using the practice of sports or recreational 
activities as an intervention, to improve the balance and/or gait outcomes.
RESULTS: 4732 articles were identified in the searches, after the removal of the duplicates articles and the 
reading of the titles and their abstracts, remained 16 articles for reading in full, being 5 trials eligible for this 
systematic review. Of the five eligible trials, three used sports activities and two recreational activities as 
intervention and presented very low-quality evidence for balance and gait outcomes. 
SIGNIFICANCE: Sports and recreational practices seem to represent promising modalities to improve the 
balance and gait of children and adolescents with SNHL. However, due to the methodological limitations of the 
trials and the low quality of the current evidence on the topic, the results of the trials should be interpreted with 
caution. Due to the low quality of evidence observed, we suggest that new trials be proposed on this topic, with 
greater methodological rigor, to provide high-quality evidence on the effectiveness of sports and recreational 
practices to improve the balance and gait of children and adolescents with SNHL.
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MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):303-306. doi: 10.15585/mmwr.mm6911a6. 
Delayed Identification of Infants Who Are Deaf or Hard of Hearing - Minnesota, 2012-2016.
Meyer AC, Marsolek M, Brown N, Coverstone K.
ABSTRACT: Few studies have examined factors associated with the timing of identification of hearing loss within 
a cohort of infants identified as deaf or hard of hearing (DHH) and what factors are associated with delayed 
identification. Minnesota Early Hearing Detection and Intervention (EHDI) personnel studied deidentified data 
from 729 infants with confirmed congenital hearing loss (i.e., hearing loss identification after not passing newborn 
hearing screening) born in Minnesota during 2012-2016. Differences in likelihood of delayed identification of 
congenital hearing loss (defined as not passing newborn hearing screening and age >3 months at the time of 
identification as DHH) based on multiple variables were analyzed. Overall, 222 (30.4%) infants identified as DHH 
had delayed identification. Multivariate regression showed that infants identified as DHH were significantly more 
likely to have delayed identification if they had 1) low birthweight, 2) public insurance, 3) a residence outside the 
metropolitan area, 4) a mother with a lower level of education, 5) a mother aged <25 years, or 6) a mother who 
was Hmong. Despite achievements of EHDI programs, disparities exist in timely identification of hearing loss. 
Using this information to develop public health initiatives that target certain populations could improve timely 
identification, reduce the risk for language delay, and enhance outcomes in children who are DHH.
J Perinat Med. 2020 Mar 26;48(3):234-241. doi: 10.1515/jpm-2019-0331. 
Prenatal findings, neonatal symptoms and neurodevelopmental outcome of congenital 
cytomegalovirus infection in a university hospital in Montreal, Quebec.
Minsart AF, Rypens F, Smiljkovic M, Kakkar F, Renaud C, Lamarre V, Boucher M, Boucoiran I.
BACKGROUND: Outcome of congenital cytomegalovirus (cCMV) infection in the absence of routine CMV 
screening and third-trimester scan in North America is scarcely documented. The aim of this study was to assess 
the severe outcomes related to cCMV according to the indication for screening. 
METHODS: This was a retrospective study of 84 mother-child pairs followed for cCMV between 2003 and 2017 
at CHU Sainte-Justine in Montreal, Canada. Prenatal ultrasound, neonatal symptoms, neuroimaging and severe 
outcomes (cerebral palsy, severe cognitive impairment, bilateral hearing loss or neonatal death) were reviewed. 
RESULTS: Among 38 cases with abnormal prenatal ultrasound, 41.9% of live-born infants developed severe 
outcomes. Sixteen (42.1%) were detected in the third trimester. Among 16 cases diagnosed prenatally because 
of maternal history, all had normal prenatal ultrasound, and none developed severe outcomes. Among cases 
diagnosed postnatally because of neonatal symptoms, 25% developed severe outcomes. All infants who 
developed severe outcomes had moderate/severe neonatal symptoms. 
CONCLUSION: Outcome of cCMV infection varies according to the reason for screening and timing of diagnosis. 
Any prenatal ultrasound anomaly might indicate a risk of severe outcome, and warrants a detailed ultrasound 
scan. However, late detection, or postnatal diagnosis, represented more than half of the cases, and awareness of 
this will help ensuring optimal management.
Am J Perinatol. 2020 Apr 10. doi: 10.1055/s-0040-1709467. 
Auditory Brainstem Evoked Response Patterns in the Neonatal Intensive Care Unit.
Mohammed ST, El-Farrash RA, Taha HM, Moustafa OA.
OBJECTIVE: Delayed maturation of auditory brainstem pathway in neonates admitted to the neonatal intensive 
care unit (NICU) may lead to misdiagnosis of children with normal peripheral hearing and inappropriate use 
of amplification devices. The aim of this study is to determine the pattern of auditory brain stem response in 
neonates admitted to the NICU for proper hearing assessment in this high-risk population. 
STUDY DESIGN: This prospective study was conducted on 1,469 infants who were admitted to the NICU, 
of which 1,423 had one or more risk factors for permanent congenital hearing loss and were screened with 
automated auditory brain stem response (AABR). A total of 60 infants were referred for diagnostic ABR analysis 
after failure on AABR screening. The control group comprised 60 well-baby nursery neonates with no risk factors 
for PCHL. 
RESULTS: Mean values of absolute latencies of waves III and V; interpeak latencies I-III, III-V, and I-V; amplitude 
of waves I, and V; and I/V amplitude ratio at 90 dBnHL measured for the right and left ears at 1 and 3 months 
of age show significant difference in NICU neonates compared with controls (p < 0.05). All the diagnostic ABR 
measurements significantly improved at the age of 3 months (p < 0.001) except wave I absolute latency of both 
groups (p > 0.05). Significant correlations were found between ABR readings at the age of 1 and 3 months and 
the gestational age of the NICU neonates (p < 0.05). 
CONCLUSION: Diagnostic ABR findings in NICU neonates suggested delayed maturation of the auditory 
brainstem pathway with a great impact of gestational age on this maturation. Auditory maturational changes were 
observed at 3 months of age of patient and control groups.
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J Infect Dis. 2020 Mar 5;221(Supplement_1):S15-S22. doi: 10.1093/infdis/jiz443. 
Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.
Mussi-Pinhata MM, Yamamoto AY.
ABSTRACT: Maternal preconceptional cytomegalovirus (CMV) immunity does not protect the fetus from acquiring 
congenital CMV infection (cCMV). Nonprimary infections due to recurrence of latent infections or reinfection 
with new virus strains during pregnancy can result in fetal infection. Because the prevalence of cCMV increases 
with increasing maternal CMV seroprevalence, the vast majority of the cases of cCMV throughout the world 
follow nonprimary maternal infections and is more common in individuals of lower socioeconomic background. 
Horizontal exposures to persons shedding virus in bodily secretions (young children, sexual activity, household 
crowding, low income) probably increase the risk of acquisition of an exogenous nonprimary CMV infection 
and fetal transmission. In addition, more frequent acquisition of new antibody reactivities in transmitter mothers 
suggest that maternal reinfection by new viral strains could be a major source of congenital infection in such 
populations. However, the exact frequency of CMV nonprimary infection in seroimmune women during pregnancy 
and the rate of intrauterine transmission in these women are yet to be defined. Usually, the birth prevalence of 
cCMV is high (≥7:1000) in highly seropositive populations. There is increasing evidence that the frequency and 
severity of the clinical and laboratory abnormalities in infants with congenital CMV infection born to mothers 
with nonprimary CMV infection are similar to infants born after a primary maternal infection. This is particularly 
true for sensorineural hearing loss, which contributes to one third of all early-onset hearing loss in seropositive 
populations. This brief overview will discuss the need for more research to better clarify the natural history of 
cCMV in highly seropositive populations, which, in almost all populations, remains incompletely defined.
Iran J Otorhinolaryngol. 2020 Jan;32(108):3-10. doi: 10.22038/ijorl.2019.37313.2219. 
Comparison of the Pediatric Cochlear Implantation Using Round Window and Cochleostomy.
Naderpour M, Aminzadeh Z, Jabbari Moghaddam Y, Pourshiri B, Ariafar A, Akhondi A.
INTRODUCTION: Cochlear implantation (CI) is now regarded as a standard treatment for children with severe 
to profound sensor neural hearing loss. This study aimed to compare the efficacy of the round window approach 
(RWA) and standard cochleostomy approach (SCA) in the preservation of residual hearing after CI in pediatric 
patients. 
MATERIALS AND METHODS: This double-blind randomized controlled trial was conducted on 97 pediatric 
patients receiving CI with 12-month follow-up. The study population was divided into two groups according to the 
surgical approaches they received, including RWA and SCA. Consequently, the patients were evaluated based on 
the Categories of Auditory Performance scale (CAP) and Speech Intelligibility Rating (SIR) test 45-60 days and 3, 
6, 9, and 12 months post-surgery. 
RESULTS: The CAP and SIR mean scores increased in both groups during the 12-month follow-up. This upward 
trend was significant in both groups (P<0.001). There was no significant difference between the two treatment 
groups in any of the follow-up stages regarding the CAP mean score. The mean SIR score (P=1.14±0.40) 
was significantly higher in the RWA group 3(P=0.001), 6(P=0.008), and 9(P=0.006) months after the surgery. 
However, there was no significant difference between the RWA and SCA groups, regarding 1-year SIR (P=0.258). 
CONCLUSION: The CI with either RWA or SCA could improve hearing and speech performance in pediatric 
patients. Although mid-term speech intelligibility was better for RWA, there was no significant difference in the 
1-year outcome between these two methods.
PLoS One. 2020 Jan 9;15(1):e0227143. doi: 10.1371/journal.pone.0227143. eCollection 2020. 
Characterization of a universal screening approach for congenital CMV infection based on a 
highly-sensitive, quantitative, multiplex real-time PCR assay.
Nagel A, Dimitrakopoulou E, Teig N, Kern P, Lücke T, Michna D, Korn K, Steininger P, Shahada K, 
Neumann K, Überla K.
ABSTRACT: The majority of congenital cytomegalovirus (cCMV) infections are asymptomatic at birth and 
therefore not diagnosed. Approximately 10-15% of these infants develop late-onset hearing loss and other 
developmental disorders. Implementation of a universal screening approach at birth may allow early initiation 
of symptomatic interventions due to a closer follow-up of infants at risk and offers the opportunity to consider 
treatment of late-onset disease. Real-time PCR assays for the detection of CMV DNA in buccal swab samples 
demonstrated feasibility and good clinical sensitivity in comparison to a rapid culture screening assay. Because 
most cCMV infections remain asymptomatic, a universal screening assay that stratifies CMV infected infants 
according to low and high risk of late-onset cCMV disease could limit the parental anxiety and reduce follow-up 
costs. We therefore developed and characterized a screening algorithm based on a highly-sensitive quantitative 
real-time PCR assay that is compatible with centralized testing of samples from universal screening and allows to 
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determine CMV DNA load of saliva samples either as International Units (IU)/ml saliva or IU/105 cell equivalents. 
18 of 34 saliva samples of newborns that tested positively by the screening algorithm were confirmed by detection 
of CMV DNA in blood and/or urine samples obtained during the first weeks of life. All screening samples that could 
not be confirmed had viral loads of <2.3x105 IU/ml saliva (median: 6.8x103) or 1.3x105 IU/105 cell equivalents 
(median: 4.0x102). The viral load of screening samples with confirmed cCMV infection ranged from 7.5x102 to 
8.2x109 IU/ml saliva (median: 9.3x107) or 1.5x102 to 5.6x1010 IU/105 cell equivalents (median: 3.5x106). Clinical 
follow-up of these newborns with confirmed cCMV infection should reveal whether the risk of late-onset cCMV 
disease correlates with CMV DNA load in early life saliva samples and whether a cut-off can be defined identifying 
cCMV infected infants with or without risk for late-onset cCMV disease.
Otolaryngol Head Neck Surg. 2020 Mar;162(3):319-321. doi: 10.1177/0194599819900492. Epub 2020 Jan 21. 
Letters to the Deaf: Present-Day Relevance of History’s Earliest Social Analysis of Deafness.
Naples J, Valdez TA.
ABSTRACT: Harriet Martineau was a 19th-century sociologist who had a progressive form of deafness. Her 
1834 essay, Letters to the Deaf, was the earliest historical document depicting the social challenges of hearing 
loss. Martineau details complex situations that hard-of-hearing people experienced in the 19th century such as 
social isolation due to frustrations with communication, physician shortcomings, limited music appreciation, and 
the stigma of hearing amplification devices. Her descriptions of these experiences are commonly faced by hard-
of-hearing people in present-day society. Advancements in technology and recognition of the negative social 
impact of hearing loss have improved the social experience for the hard of hearing; however, social challenges 
remain relevant. In this article, we review Letters to the Deaf and note the ways in which this essay provides a 
dual perspective regarding how much we have advanced as a society and how much we still have to overcome in 
addressing the social challenges of hearing loss.
Acta Otorrinolaringol Esp. 2020 Jan - Feb;71(1):45-55. doi: 10.1016/j.otorri.2018.09.004. Epub 2018 Dec 19. 
Early diagnosis and treatment of unilateral or asymmetrical hearing loss in children: 
CODEPEH recommendations.
Núñez-Batalla F, Jáudenes-Casaubón C, Sequí-Canet JM, Vivanco-Allende A, Zubicaray-Ugarteche J.
ABSTRACT: The aim of this document is to improve the management and the treatment of unilateral or 
asymmetrical hearing loss in children. One in one thousand newborn infants has unilateral hearing loss and this 
prevalence increases with age, due to cases of acquired and delayed-onset hearing loss. Although the impact on 
the development and learning processes of children of these kinds of hearing loss have usually been minimized, 
if they are not treated they will impact on language and speech development, as well as overall development, 
affecting the quality of life of the child and his/her family. The outcomes of the review are expressed as 
recommendations aimed at clinical diagnosis and therapeutic improvement for unilateral or asymmetrical hearing loss.
Acta Med Port. 2019 Dec 2;32(12):767-775. doi: 10.20344/amp.11880. Epub 2019 Dec 2. [Article in Portuguese]
Congenital or Early Acquired Deafness: An Overview of the Portuguese Situation, from 
Diagnosis to Follow-Up.
Oliveira C, Machado M, Zenha R, Azevedo L, Monteiro L, Bicho A.
INTRODUCTION: Congenital deafness or early acquired deafness affects 1 to 3 out of 1000 newborns without 
risk factors and 20 to 40 out of 1000 newborns with risk factors. The universal newborn hearing screening enables 
its early identification. Children with congenital deafness/early acquired deafness have a higher prevalence of 
other conditions, especially ophthalmologic and neurodevelopmental ones, and at least 30% to 40% have at least 
one associated comorbidity. 
MATERIAL AND METHODS: We carried out a cross-sectional, multicenter study in which 83% (n = 30) of the 
hospitals/maternity hospitals of the National Health Service participated. 
RESULTS: All surveyed hospitals/maternity hospitals routinely performed universal newborn hearing screening to 
all newborns before discharge; 63% referred children with risk factors for hearing loss to Otorhinolaryngology. All 
children with congenital deafness/early acquired deafness are referred to: Pediatrics in 23% hospitals/maternity 
hospitals. In 23 hospitals/maternity hospitals, all children with congenital deafness/early acquired deafness are 
referred to: Speech Therapy in 44% hospitals/ maternity hospitals; Ophthalmology in 17% hospitals/maternity 
hospitals; National System of Early Intervention in Childhood in 30% hospitals/maternity hospitals; 22% of 
hospitals/maternity hospitals refer all children with congenital deafness/early acquired deafness, with no identified 
cause, to Clinical Genetics clinics. The number of diagnoses of deafness in the years 2014 and 2015 was 2.5 and 
1.5 per 1000 newborns, respectively, in 15 hospitals/maternity hospitals. 
DISCUSSION: Awareness of universal newborn hearing screening seems to be widely spread in the National 
Health Service. The number of children with SC / SPA, as well as the percentage of different types of deafness 
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diagnosed, were identical to those found in other studies and shows its importance. The assessment / follow-up 
of these children by specialties other than the otolaryngology was heterogeneous in different health entities and 
revealed that not all children with risk factors for deafness follow up advised by existing standards. 
CONCLUSION: Results show that Portugal made an important path in the screening and follow-up of children 
with SC / SPA. It is important, with the ultimate aim of continually improving the care of these children, to reflect 
on the involvement of specialties other than otolaryngology, such as the National Early Childhood Intervention 
System in the follow-up of these children.
Indian J Otolaryngol Head Neck Surg. 2020 Mar;72(1):30-35. doi: 10.1007/s12070-019-01723-w. Epub 2019 Jul 31. 
A Prospective Study on Temporal Bone Involvement in Polytrauma Patients and the Effect of 
Early Diagnosis on Hearing Loss.
Padmakumar V, Ramesh Kumar E, Ramakrishnan VR.
ABSTRACT: As polytrauma cases are on the rise, a large number of patients presents with temporal bone 
fractures, which can result in various types of injuries varying from trivial to more serious injuries. Early diagnosis 
and appropriate management in required in case of serious injuries for a better outcome. The aim of my study is 
to study the incidence, the different injuries occurring and the effect of early diagnosis on hearing loss. Patients 
coming to our emergency department with polytrauma are studied and clinically evaluated for any temporal bone 
injuries. Based on the type of injuries audiological and radiological studies are done. And if required, biochemical 
tests like CSF analysis will be done. Also hearing assessment will be done as early as possible and appropriate 
treatment required will be started. The outcome is then assessed and followed up on a regular basis. In our 
study there were 90 patients with temporal bone fracture out of the 2748 polytrauma cases. The incidence was 
calculated to be 32 per 1000 cases. 69 patients (76.7%) had longitudinal fracture of temporal bone; 13 patients 
(14.4%) had transverse fracture; 2 patients (2.2%) had oblique fractures and 6 patients (6.6%) had comminuted 
fractures. Hearing loss was found to be the most common injury seen in 56 patients (62.2%). Of which 30 (53.5%) 
had conductive hearing loss (CHL); 9 (16%) had sensorineural hearing loss (SNHL); 17 had mixed hearing loss 
(MHL). 27 (90%) out of 30 patients with CHL showed improvement in hearing. Out of the 26 patients with SNHL 
and MHL, 22 patients (84.61%) showed improvement. 5 out of 6 with immediate onset facial palsy and 6 out of 8 
with late onset facial palsy showed improvement. The hearing outcome in our study was found to be much better 
than the previous year which shows that the difference might be due to the early diagnosis and management. In 
our study hearing improvement was noted in most patients with hearing loss when compared to the previous year, 
which may have been due to the detection of the injuries at the earliest and managing the same with appropriate 
treatment modalities.
Mol Genet Genomic Med. 2020 Feb 17:e1171. doi: 10.1002/mgg3.1171. 
Analyses of del(GJB6-D13S1830) and del(GJB6-D13S1834) deletions in a large cohort with 
hearing loss: Caveats to interpretation of molecular test results in multiplex families.
Pandya A1, O’Brien A1, Kovasala M1, Bademci G2, Tekin M2, Arnos KS3.
BACKGROUND: Mutations involving the closely linked GJB2 and GJB6 at the DFNB1 locus are a common 
genetic cause of profound congenital hearing loss in many populations. In some deaf GJB2 heterozygotes, a 
309 kb deletion involving the GJB6 has been found to be the cause for hearing loss when inherited in trans to a 
GJB2 mutation. 
METHODS: We screened 2,376 probands from a National DNA Repository of deaf individuals. 
RESULTS: Fifty-two of 318 heterozygous probands with pathogenic GJB2 sequence variants had a GJB6 
deletion. Additionally, eight probands had an isolated heterozygous GJB6 deletion that did not explain their 
hearing loss. In two deaf subjects, including one proband, a homozygous GJB6 deletion was the cause for their 
hearing loss, a rare occurrence not reported to date. 
CONCLUSION: This study represents the largest US cohort of deaf individuals harboring GJB2 and GJB6 
variants, including unique subsets of families with deaf parents. Testing additional members to clarify the phase 
of GJB2/GJB6 variants in multiplex families was crucial in interpreting clinical significance of the variants in 
the proband. It highlights the importance of determining the phase of GJB2/GJB6 variants when interpreting 
molecular test results especially in multiplex families with assortative mating.
BMC Infect Dis. 2020 Mar 12;20(1):217. doi: 10.1186/s12879-020-4941-z. 
Diagnosing congenital Cytomegalovirus infection: don’t get rid of dried blood spots.
Pellegrinelli L, Alberti L, Pariani E, Barbi M, Binda S.
BACKGROUND: Congenital Cytomegalovirus (cCMV) is a serious global public health issue that can cause 
irreversible fetal and neonatal congenital defects in symptomatic or asymptomatic newborns at birth. In absence 
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of universal cCMV screening, the retrospective diagnosis of cCMV infection in children is only possible by 
examining Dried Blood Spot (DBS) samples routinely collected at birth and stored for different time spans 
depending on the newborn screening regulations in force in different countries. In this article, we summarize the 
arguments in favor of long-term DBS sample storage for detecting cCMV infection. 
MAIN TEXT: CMV infection is the most common cause of congenital infection resulting in severe defects and 
anomalies that can be apparent at birth or develop in early childhood. Sensorineural hearing loss is the most 
frequent consequence of cCMV infection and may have a late onset and progress in the first years of life. The 
virological diagnosis of cCMV is essential for clinical research and public health practices. In fact, in order to 
assess the natural history of CMV infection and distinguish between congenital or acquired infection, children 
should be diagnosed early by analyzing biological samples collected in the first weeks of life (3 weeks by using 
viral culture and 2 weeks by molecular assays), which, unfortunately, are not always available for asymptomatic 
or mildly symptomatic children. It now seems possible to overcome this problem since the CMV-DNA present 
in the blood of congenitally infected newborns can be easily retrieved from the DBS samples on the Guthrie 
cards routinely collected and stored within 3 days from birth in the neonatal screening program for genetic and 
congenital diseases. Early collection and long-term storage are inexpensive methods for long-term bio-banking 
and are the key points of DBS testing for the detection of cCMV. 
CONCLUSION: DBS sampling is a reliable and inexpensive method for long-term bio-banking, which enables 
to diagnose known infectious diseases - including cCMV - as well as diseases not jet recognized, therefore their 
storage sites and long-term storage conditions and durations should be the subject of political decision-making.
Laryngoscope. 2020 Jan 27. doi: 10.1002/lary.28536. 
Genetic Testing for Congenital Bilateral Hearing Loss in the Context of Targeted 
Cytomegalovirus Screening.
Peterson J, Nishimura C, Smith RJH.
OBJECTIVES/HYPOTHESIS: To determine the prevalence of children with genetic hearing loss who are 
cytomegalovirus (CMV) positive at birth and the relative proportion of genetic and CMV etiology among children 
with congenital bilateral hearing loss. 
STUDY DESIGN: Database review. 
METHODS: We performed a review of clinical test results for patients undergoing comprehensive genetic testing 
for all known hearing loss-associated genes from January 2012 to January 2019. This population was reviewed 
for reported CMV status and genetic causes of congenital bilateral hearing loss. 
RESULTS: In the OtoSCOPE database, 61/4,282 patients were found to have a documented CMV status, and 
661/4282 had documented bilateral congenital hearing loss. Two patients were identified who had both a positive 
CMV result and a genetic cause for their hearing loss. Forty-eight percent of patients with bilateral congenital 
hearing loss (320/661) were found to have a genetic etiology. In 62% (198/320), the hearing loss was associated 
with pathogenic variants in GJB2, STRC, SLC26A4 or an Usher syndrome-associated gene. 
CONCLUSIONS: We estimate that ~2% of CMV-positive newborns with hearing loss have a known genetic 
variant as a cause. The subcohort of CMV-positive newborns with symmetric mild-to-moderate bilateral hearing 
loss will have at least a 7% chance of having pathogenic gene variants associated with hearing loss. In a CMV-
positive neonate who failed their newborn hearing screen bilaterally, genetic screening needs to be considered for 
accurate diagnosis and possible deferment of antiviral treatment.
J Pediatr Hematol Oncol. 2020 Jan;42(1):e25-e31. doi: 10.1097/MPH.0000000000001637. 
Platinum-drugs Ototoxicity in Pediatric Patients With Brain Tumors: A 10-Year Review.
Rabiço-Costa D, Gil-da-Costa MJ, Barbosa JP, Bom-Sucesso M, Spratley J.
PURPOSE: Platinum-derived chemotherapy is one of the cornerstones in the treatment of central nervous system 
tumors in children. We aimed to assess the incidence of hearing loss in children after the exposure to platinum drugs. 
MATERIAL AND METHODS: Retrospective study of prospectively collected data on children consecutively 
diagnosed with brain tumors and treated with platinum derivatives at a tertiary referral hospital between 
January 2006 and December 2015. We analyzed multiples variables, such as: age at diagnosis, tumor location, 
hydrocephalus, platinum drug type, radiotherapy, and follow-up time. The final sample size was 51 patients. 
RESULTS: The median age at diagnosis was 6 years. The median overall follow-up time was 75 months. The 
incidence of ototoxicity was 23.5%. Rates of hearing loss with carboplatinum were lower than with cisplatinum. 
A statistically significant association occurred between the presence of hydrocephalus, radiotherapy exposure, 
infratentorial tumor location, and ototoxicity after treatment with platinum derivatives. 
CONCLUSIONS: Childhood central nervous system tumors nowadays exhibit improved cure and survival rates. 
However, the ototoxicity resulting from the chemotherapy treatment may accompany patients for the rest of 
their lives. This study reveals that this occurrence is not negligible, and the association of radiotherapy and the 
presence of hydrocephalus can be potentiating factors.
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Am J Med Genet B Neuropsychiatr Genet. 2020 Apr;183(3):172-180. doi: 10.1002/ajmg.b.32774. Epub 2019 Dec 19. 
Identification of TMC1 as a relatively common cause for nonsyndromic hearing loss in the 
Saudi population.
Ramzan K, Al-Owain M, Al-Numair NS, Afzal S, Al-Ageel S, Al-Amer S, Al-Baik L, Al-Otaibi GF, 
Hashem A, Al-Mashharawi E, Basit S, Al-Mazroea AH, Softah A, Sogaty S, Imtiaz F.
ABSTRACT: Hearing loss (HL) is the most common sensory disorder worldwide and genetic factors contribute to 
approximately half of congenital HL cases. HL is subject to extensive genetic heterogeneity, rendering molecular 
diagnosis difficult. Mutations of the transmembrane channel-like 1 (TMC1) gene cause hearing defects in humans 
and mice. The precise function of TMC1 protein in the inner ear is unknown, although it is predicted to be 
involved in functional maturation of cochlear hair cells. TMC1 mutations result in autosomal recessive (DFNB7/11) 
and sometimes dominant (DFNA36) nonsyndromic HL. Mutations in TMC1 are responsible for a significant 
portion of HL, particularly in consanguineous populations. To evaluate the importance of TMC1 mutations in 
the Saudi population, we used a combination of autozygome-guided candidate gene mutation analysis and 
targeted next generation sequencing in 366 families with HL previously shown to lack mutations in GJB2. We 
identified 12 families that carried five causative TMC1 mutations; including three novel (c.362+3A > G; c.758C > T 
[p.Ser253Phe]; c.1396_1398delACC [p.Asn466del]) and two reported mutations (c.100C > T [p.Arg34Ter]; 
c.1714G > A [p.Asp572Asn]). Each of the identified recessive mutation was classified as severe, by both age of 
onset and severity of HL. Similarly, consistent with the previously reported dominant variant p.Asp572Asn, the HL 
phenotype was progressive. Eight families in our cohort were found to share the pathogenic p.Arg34Ter mutation 
and linkage disequilibrium was observed between p.Arg34Ter and SNPs investigated. Our results indicate that 
TMC1 mutations account for about 3.3% (12/366) of Saudi HL cases and that the recurrent TMC1 mutation 
p.Arg34Ter is likely to be a founder mutation.
Wiley Interdiscip Rev Syst Biol Med. 2020 Mar;12(2):e1469. doi: 10.1002/wsbm.1469. Epub 2019 Dec 4. 
Structural neuroimaging of the altered brain stemming from pediatric and adolescent hearing 
loss-Scientific and clinical challenges.
Ratnanather JT.
ABSTRACT: There has been a spurt in structural neuroimaging studies of the effect of hearing loss on the 
brain. Specifically, magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) technologies provide 
an opportunity to quantify changes in gray and white matter structures at the macroscopic scale. To date, there 
have been 32 MRI and 23 DTI studies that have analyzed structural differences accruing from pre- or peri-
lingual pediatric hearing loss with congenital or early onset etiology and postlingual hearing loss in pre-to-late 
adolescence. Additionally, there have been 15 prospective clinical structural neuroimaging studies of children and 
adolescents being evaluated for cochlear implants. The results of the 70 studies are summarized in two figures 
and three tables. Plastic changes in the brain are seen to be multifocal rather than diffuse, that is, differences 
are consistent across regions implicated in the hearing, speech and language networks regardless of modes of 
communication and amplification. Structures in that play an important role in cognition are affected to a lesser 
extent. A limitation of these studies is the emphasis on volumetric measures and on homogeneous groups of 
subjects with hearing loss. It is suggested that additional measures of morphometry and connectivity could 
contribute to a greater understanding of the effect of hearing loss on the brain. Then an interpretation of the 
observed macroscopic structural differences is given. This is followed by discussion of how structural imaging can 
be combined with functional imaging to provide biomarkers for longitudinal tracking of amplification. 
J Infect Dis. 2020 Mar 5;221(Supplement_1):S74-S85. doi: 10.1093/infdis/jiz601. 
Clinical Diagnostic Testing for Human Cytomegalovirus Infections.
Razonable RR, Inoue N, Pinninti SG, Boppana SB, Lazzarotto T, Gabrielli L, Simonazzi G, Pellett PE, 
Schmid DS.
ABSTRACT: Human cytomegalovirus (HCMV) infections are among the most common complications arising in 
transplant patients, elevating the risk of various complications including loss of graft and death. HCMV infections 
are also responsible for more congenital infections worldwide than any other agent. Congenital HCMV (cCMV) 
infections are the leading nongenetic cause of sensorineural hearing loss and a source of significant neurological 
disabilities in children. While there is overlap in the clinical and laboratory approaches to diagnosis of HCMV 
infections in these settings, the management, follow-up, treatment, and diagnostic strategies differ considerably. 
As yet, no country has implemented a universal screening program for cCMV. Here, we summarize the issues, 
limitations, and application of diagnostic strategies for transplant recipients and congenital infection, including 
examples of screening programs for congenital HCMV that have been implemented at several centers in Japan, 
Italy, and the United States.
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Am J Otolaryngol. 2020 Mar - Apr;41(2):102372. doi: 10.1016/j.amjoto.2019.102372. Epub 2019 Dec 10. 
Impact of cochlear abnormalities on hearing outcomes for children with cochlear implants.
Ronner E, Basonbul R, Bhakta R, Mankarious L, Lee DJ, Cohen MS.
OBJECTIVE: Evaluate the impact of cochlear anomalies on hearing outcomes for pediatric patients with cochlear 
implants. 
STUDY DESIGN: Retrospective chart review. 
SETTING: Tertiary care center. 
SUBJECTS AND METHODS: Charts were retrospectively reviewed for cases where pediatric cochlear implant 
surgery was performed between 2002 and 2018 at a single, tertiary care institution. Patients were divided into 
groups based on the presence or absence of radiological cochlear abnormalities, which were further classified 
as low or high risk anomalies. Hearing outcomes were evaluated by measuring pure tone averages and word 
recognition scores preoperatively, 3 and 12 months postoperatively, in addition to the most recent test results. 
RESULTS: There were 154 ears implanted in our cohort of 100 patients. 107 ears had normal cochlear anatomy, 
31 had low risk, and 16 had high risk abnormalities. The most common modality of preoperative imaging was CT 
scan. Postoperative mean pure tone average (PTA) was significantly higher in patients with inner ear anomalies 
compared to those with normal anatomy. No significant difference in PTA was noted between low versus high 
risk patients. <50% of patients had word recognition scores available within the first year following surgery. 
CONCLUSION: Abnormalities of the inner ear significantly influenced hearing outcomes over time following 
cochlear implant surgery when compared to pediatric patients with normal anatomy. Obtaining hearing testing can 
be difficult in very young children and therefore future studies are warranted to further investigate the impact that 
cochlear abnormalities may have on hearing outcomes following cochlear implant surgery.
Int J Pediatr Otorhinolaryngol. 2020 Apr;131:109870. doi: 10.1016/j.ijporl.2020.109870. Epub 2020 Jan 10. 
Outcomes of regional-based newborn hearing screening for 35,461 newborns for 5 years in 
Akita, Japan.
Sato T, Nakazawa M, Takahashi S, Mizuno T, Ishikawa K, Yamada T.
OBJECTIVES: Newborn hearing screening (NHS) has been actively performed since 2001 in Akita, Japan. The 
NHS coverage rate has increased yearly, and performance has been consistently >90% since 2012. The purpose 
of this study was to summarize NHS outcomes in the Akita prefecture of Japan and to obtain new insights for from 
our summarized data for the future. 
METHODS: A total of 35,461 newborns in hospitals and clinics where hearing screening was performed in Akita 
from 2012 to 2016 were included. The outcome data of NHS were collected for analysis. 
RESULTS: The overall screening coverage rate for hearing loss was 94.7%. Of the screened infants, 0.53% 
received a referral on the 2-stage automated auditory brainstem response (ABR), and 80.4% of referred infants 
had a check-up at the hospital to receive a diagnostic hearing examination. Finally, the prevalence of bilateral 
congenital hearing loss was 0.14%, that of bilateral moderate to profound hearing loss was 0.12%, and that of 
unilateral congenital hearing loss was 0.10%. Furthermore, the average consultation period in infants with risk 
factors was significantly later than that in infants without risk factors (p = 0.0015). Follow-up for infants diagnosed 
with normal hearing after diagnostic hearing examination revealed that 4.7% suffered bilateral moderate to 
profound hearing loss later. This percentage is significantly higher than that of the general group (p < 0.001). 
CONCLUSION: The prevalence of bilateral congenital hearing loss was 0.14% in Akita and 0.12% of infants were 
diagnosed with bilateral moderate to severe hearing loss. Medical personnel should be enlightened regarding the 
importance of performing hearing diagnostic examinations until 3 months of age. Even if infants were diagnosed 
with normal hearing after a diagnostic examination, we strongly suggest continuing follow-up until they are able to 
perform pure tone audiometry with accuracy.
HNO. 2020 Mar 5. doi: 10.1007/s00106-020-00825-0. [Epub ahead of print] [Article in German]
Guideline: Auditory processing and perception disorders: Proposal for treatment and 
management of APD : S1 guideline of the German Society of Phoniatrics and Pediatric 
Audiology.
Schönweiler R, Kiese-Himmel C, Plotz K, Nickisch A, Am Zehnhoff-Dinnesen A.
ABSTRACT: Despite normal hearing thresholds in pure-tone audiometry, 0.5-1% of children have difficulty 
understanding what they hear. An auditory processing disorder (APD) can be assumed, which should be clarified 
and treated. In patients with hearing loss, this must first be compensated or resolved. Only hereafter can a 
suspected APD be confirmed or excluded. Diagnosis of APD requires that a clear discrepancy between the 
child’s performance in individual auditory functions and other cognitive abilities be demonstrated. Combination 
of therapeutical modalities is considered particularly more beneficial in APD patients than a single modality. 
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Treatment modalities should consider linguistic and cognitive processes (top-down), e.g., metacognitive 
knowledge of learning strategies or vocabulary expansion, but also address underlying auditory deficits (bottom-
up). Almost 50% of children with APD also have a language development disorder requiring treatment and/or 
dyslexia. Therefore, each therapeutic intervention for a child with APD must be individually adapted according 
to the diagnosed impairments. Musical training can improve phonologic and reading abilities. Changes and 
adaptations in the classroom are helpful to support the weak auditory system of children with APD. Architectural 
planning of classrooms can be a means of ensuring that direct sound is masked by as little diffuse sound as 
possible. For example, acoustic ceiling tiles are suitable for reducing reverberant and diffuse sound.
Int J Pediatr Otorhinolaryngol. 2020 Mar 9;133:109984. doi: 10.1016/j.ijporl.2020.109984. 
Hearing and speech benefits of cochlear implantation in children: A review of the literature.
Sharma SD, Cushing SL, Papsin BC, Gordon KA.
ABSTRACT: Cochlear implantation is a safe and reliable treatment for children with severe to profound hearing 
loss. The primary benefit of these medical devices in children is the acquisition of hearing, which promotes 
development of spoken language. The present paper reviews published literature demonstrating predictive effects 
of a number of factors on acquisition of hearing development and speech recognition. Of the many variables that 
contribute to an individual child’s development after implantation, age at implantation, the presence of medical 
comorbidities, social determinants of health, and the provision of bilateral versus unilateral hearing are those 
that can vary widely and have consistently shown clear impacts. Specifically, age of implantation is crucial to 
reduce effects of deafness on the developing auditory system and capture the remarkable plasticity of early 
development. Language development after cochlear implantation requires therapy emphasizing hearing and 
oral communication, education, and other support which can be influenced by known social determinants of 
health; specifically, outcomes in children decline with reductions in socioeconomic status and levels of parental 
education. Medical co-morbidities also slow rates of progress after cochlear implantation. On the other hand, 
benefits of implantation increase in children who are provided with access to hearing from both ears. In sum, 
cochlear implants promote development of hearing in children and the best outcomes are achieved by providing 
early access to sound in both ears. These benefits can be limited by known social determinants of health which 
restrict access to needed support and medical comorbidities which add further complexity in care and outcome.
Int J Pediatr Otorhinolaryngol. 2020 Apr;131:109881. doi: 10.1016/j.ijporl.2020.109881. Epub 2020 Jan 16. 
Comprehensive hearing care network for early identification and intervention in children with 
congenital and late-onset/acquired hearing loss: 8 years’ experience in Miyazaki.
Shirane M, Ganaha A, Nakashima T, Shimoara S, Yasunaga T, Ichihara S, Kageyama S, Matsuda Y, Tono T.
OBJECTIVE: In 2010, we established the Miyazaki Comprehensive Hearing Care Network (MCHCN) for early 
identification and intervention in children with congenital and late-onset/acquired hearing loss with the cooperation 
of related administrative bodies in Miyazaki prefecture. The central roles of the MCHCN program are played by 
the Hearing Care Center (HCC) at the University of Miyazaki Hospital established in 2010 to facilitate audiological 
diagnoses, hearing aid interventions, and educational efforts, as well as linkage with the Department of 
Otolaryngology for surgical interventions. Herein, we aimed to present the main outcomes of the MCHCN program 
organized by the HCC at the University of Miyazaki Hospital. 
METHODS: The MCHCN consists of two different networks, the Newborn Hearing Screening Network (NHSN) 
and the Pediatric Hearing Care Network (PHCN). All children suspected of having hearing loss by Newborn 
Hearing Screening (NHS) are referred to the HCC via the NHSN. In addition, children suspected of late-onset/
acquired hearing loss by municipality-led health checkups, pediatricians, public health nurses, and childcare 
workers are referred to the HCC via the PHCN. Children who were born in Miyazaki prefecture between January 
2010 and December 2017 and referred to the HCC for detailed hearing examination were included in this study. 
RESULTS: Within the study period, 89,390 infants were born in Miyazaki prefecture, and 84,737 (94.9%) of them 
underwent NHS. A total of 698 infants and 182 children with suspected hearing loss were referred to the HCC via 
the NHSN and PHCN, respectively. Of the 880 referrals, 169 were diagnosed with hearing loss, which included 
80 children with bilateral hearing loss and 89 children with unilateral hearing loss. Of the 80 children with bilateral 
hearing loss, 76 began wearing hearing aids and 15 had cochlear implants in the follow-up period. In children 
with bilateral conductive hearing loss, 4 children with bilateral middle ear anomalies underwent ossiculoplasty, 
following which two of these children no longer required hearing aids. Imaging assessments performed on 71 of 
the 89 children with unilateral hearing loss revealed that 20 of the 30 (66%) children who underwent CT exhibited 
ossicular anomalies and 28 out of the 48 (58%) children who underwent MRI were found to have ipsilateral 
cochlear nerve hypoplasia. Among the 169 children with hearing loss, no follow-up loss was observed during the 
period of this study. 
CONCLUSION: The MCHCN that was organized at the initiative of the HCC at the University of Miyazaki Hospital 
has enabled the provision of comprehensive and continuous support, ranging from diagnosis to intervention, not 
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only for children with suspected hearing loss referred based on their NHS results but also for those who pass the 
screening. Via this system, children with late-onset/acquired hearing loss can be identified early and can receive 
medical interventions tailored to the cause of their hearing loss while simultaneously avoiding a loss to follow-up.
Int J Pediatr Otorhinolaryngol. 2020 Mar 6;133:109983. doi: 10.1016/j.ijporl.2020.109983. 
Endoscopic findings and long-term hearing results for pediatric unilateral conductive hearing loss.
Silvola JT.
OBJECTIVES: Analyze reasons for unilateral conductive hearing loss (CHL) with unknown etiology in children. 
INTRODUCTION: Unilateral conductive hearing loss (HL) without known etiology can be undiagnosed despite of 
hearing screening programs. It can be difficult to find the reason for HL and to make a treatment plan. Middle ear 
endoscopy gives hard-evidence diagnosis and basis for an individual treatment plan. 
METHODS AND MATERIAL: Prospective clinical follow-up study for a cohort of generally healthy elementary 
school age children with unilateral conductive HL with unknown etiology. The study population was 192 children, 
of which 46 had a HL of at least 25 dB with more than 10 dB conductive component. Mean age was 8.7 years. 
Preoperative tests included otomicroscopy, bone- and air-conduction audiogram, tympanometry, stapes reflex 
tests, Rinne and Weber test and Otoacoustic emissions. The children underwent endoscopy of the middle ear 
with an individual treatment plan and long-term follow-up. The aim was to explore etiology and to give a treatment 
plan for hearing loss. Follow-up included air- and bone conduction hearing tests annually or every other year. 
Mean follow-up was 5.2 years. 
RESULTS: A clear etiological finding was found in 36 (78%) ears, stapes anomaly (23) as the most common 
(64%) finding. Other findings were two cholesteatomas, 2 status after trauma, 5 middle ear anomalies, 5 incus 
fixations and one incus erosion. Air conduction hearing improved spontaneously during follow-up in 81% 
(17/21, 2 dropouts) of the stapes anomaly ears (mean 11,3 dB, range 4-32 dB), and none of these ears showed 
hearing deterioration. In the incus fixation group, one ear showed hearing deterioration. There were no major 
complications for exploration, and 5 minor postoperative infections. 
CONCLUSIONS: The most common reason for pediatric unilateral conductive hearing loss was stapes anomaly/
fixation. The HL does not deteriorate. Hearing loss in stapes anomalies shows a tendency for spontaneous 
recovery. Stapes surgery can be postponed or avoided.
Aust J Prim Health. 2020 Jan 20. doi: 10.1071/PY18162. 
Developmental vulnerability of Australian school-entry children with hearing loss.
Simpson A, Šarkić B, Enticott JC, Richardson Z, Buck K.
ABSTRACT: National data from the Australian Early Development Census (AEDC) was used to describe the 
sociodemographic and developmental characteristics of a cohort of Australian children entering their first year of 
primary school in 2012. Results, together with sociodemographic variables were reported for two groups: children 
with and without reported hearing loss. Data on 285232 children were analysed, with just over 1% of these 
children identified with hearing loss. Logistic regression analysis found that children with reported hearing loss 
had over double the odds than their hearing peers of being developmentally ‘vulnerable’ on one or more domains 
of the AEDC. Covariates of interest included Aboriginal and Torres Strait Islander heritage, as well as high rates of 
school absenteeism. Retrospective longitudinal research linking developmental outcomes with intervention efforts, 
such as newborn hearing screening, would be beneficial in future research.
Am J Otolaryngol. 2020 Jan 10:102398. doi: 10.1016/j.amjoto.2020.102398. 
The effect of passive smoking on the etiology of serous otitis media in children.
Tarhun YM.
ABSTRACT: Serous otitis media (SOM) is a disease mostly seen in the pediatric age group and characterized 
by serous effusion in the middle ear. The disease which is mostly silent can cause permanent hearing loss if it 
is not diagnosed and treated early. Passive smoking is one of the environmental factors in the etiopathology of 
the disease and risk factors for SOM formation in children. In our study, smoking habits of family members of 75 
children with SOM and 50 healthy controls were investigated. At the end of the study, the correlation between 
SOM and passive smoke exposed was statistically significant in children (p < 0.01). In this study, the effect of 
passive smoking, which is a preventable and controllable risk factor in the etiology of the SOM in children is emphasized.
BMC Infect Dis. 2020 Mar 17;20(1):225. doi: 10.1186/s12879-020-4950-y. 
Bacterial otitis media in sub-Saharan Africa: a systematic review and meta-analysis.
Tesfa T, Mitiku H, Sisay M, Weldegebreal F, Ataro Z, Motbaynor B, Marami D, Teklemariam Z.
BACKGROUND: Otitis media is inflammation of the middle ear, comprising a spectrum of diseases. It is the 
commonest episode of infection in children, which often occurs after an acute upper respiratory tract infection. 
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Otitis media is ranked as the second most important cause of hearing loss and the fifth global burden of disease 
with a higher incidence in developing worlds like Sub-Saharan Africa and South Asia. Therefore, this systematic 
review is aimed to quantitatively estimate the current status of bacterial otitis media, bacterial etiology and their 
susceptibility profile in sub-Saharan Africa. 
METHODS: A literature search was conducted from major databases and indexing services including EMBASE 
(Ovid interface), PubMed/MEDLINE, Google Scholar, ScienceDirect, Cochrane Library, WHO African Index-
Medicus and others. All studies (published and unpublished) addressing the prevalence of otitis media and clinical 
isolates conducted in sub-Saharan Africa were included. Format prepared in Microsoft Excel was used to extract 
the data and data was exported to Stata version 15 software for the analyses. Der-Simonian-Laird random-effects 
model at a 95% confidence level was used for pooled estimation of outcomes. The degree of heterogeneity was 
presented with I2 statistics. Publication bias was presented with funnel plots of standard error supplemented 
by Begg’s and Egger’s tests. The study protocol is registered on PROSPERO with reference number ID: 
CRD42018102485 and the published methodology is available from http://www.crd.york.ac.uk/CRD42018102485. 
RESULTS: A total of 33 studies with 6034 patients were included in this study. All studies have collected ear 
swab/discharge samples for bacterial isolation. The pooled isolation rate of bacterial agents from the CSOM 
subgroup was 98%, patients with otitis media subgroup 87% and pediatric otitis media 86%. A univariate meta-
regression analysis indicated the type of otitis media was a possible source of heterogeneity (p-value = 0.001). 
The commonest isolates were P. aeruginosa (23-25%), S. aureus (18-27%), Proteus species (11-19%) 
and Klebsiella species. High level of resistance was observed against Ampicillin, Amoxicillin-clavulanate, 
Cotrimoxazole, Amoxicillin, and Cefuroxime. 
CONCLUSION: The analysis revealed that bacterial pathogens like P. aeruginosa and S. aureus are majorly 
responsible for otitis media in sub-Saharan Africa. The isolates have a high level of resistance to commonly used 
drugs for the management of otitis media.
Otolaryngol Head Neck Surg. 2020 Jan;162(1):114-120. doi: 10.1177/0194599819880348. Epub 2019 Oct 8. 
Should You Follow the Better-Hearing Ear for Congenital Cytomegalovirus Infection and 
Isolated Sensorineural Hearing Loss?
Torrecillas V, Allen CM, Greene T, Park A, Chung W, Lanzieri TM, Demmler-Harrison G.
OBJECTIVE: To describe the progression of sensorineural hearing loss (SNHL) in the better- and poorer-hearing 
ears in children with asymptomatic congenital cytomegalovirus (CMV) infection with isolated SNHL. STUDY 
DESIGN: Longitudinal prospective cohort study. 
SETTING: Tertiary medical center. 
SUBJECTS AND METHODS: We analyzed hearing thresholds of the better- and poorer-hearing ears of 16 CMV-
infected patients with isolated congenital/early-onset or delayed-onset SNHL identified through hospital-based 
CMV screening of >30,000 newborns from 1982 to 1992. 
RESULTS: By 12 months of age, 4 of 7 patients with congenital/early-onset SNHL developed worsening 
thresholds in the poorer-hearing ear, and 1 had an improvement in the better-hearing ear. By 18 years of age, all 7 
patients had worsening thresholds in the poorer-hearing ear and 3 patients had worsening thresholds in the better-
hearing ear. plHearing loss first worsened at a mean age of 2 and 6 years in the poorer- and better-hearing ears, 
respectively. Nine patients were diagnosed with delayed-onset SNHL (mean age of 9 years vs 12 years for the 
poorer- and better-hearing ears), 6 of whom had worsening thresholds in the poorer-hearing ear and 1 in both ears. 
CONCLUSION: In most children with congenital CMV infection and isolated SNHL, the poorer-hearing ear 
worsened earlier and more precipitously than the better-hearing ear. This study suggests that monitoring 
individual hearing thresholds in both ears is important for appropriate interventions and future evaluation of 
efficacy of antiviral treatment.
Eur Arch Otorhinolaryngol. 2020 Mar 27. doi: 10.1007/s00405-020-05935-7. 
Assessment of temporal processing functions in early period cochlear implantation.
Tuz D, Aslan F, Böke B, Yücel E.
PURPOSE: The purpose of this study is to compare the temporal processing performance of children with 
cochlear implant (CI) according to the age of implantation and to determine their relation with auditory perception 
scores. 
METHODS: In this study, 30 cochlear implant users and ten normal hearing children at 9 and 10 years were 
included. Children with cochlear implants are divided into two groups according to the age of implantation: group 
I includes participants whose implantation age is between 13 and 35 months (20 children), group II includes 
participants whose implantation age is between 36 and 45 months (10 children). Individuals were evaluated with 
random gap detection test (RGDT), duration pattern test (DPT), frequency pattern test (FPT), the Mr. Potato Head 
task, word recognition, and sentence recognition test. 
RESULTS: A significant difference was found between the control and CI groups in temporal processing 
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performance. The temporal processing ability of CI groups was significantly worse than those of normal 
hearing. Although there was no significant difference among the groups with cochlear implant in terms of 
temporal processing performance, children who started to use CI at an earlier age showed a tendency of better 
performance on temporal processing tasks. There was a significant relationship between Daily Sentence Test and 
FPT, and the Mr. Potato Head task and FPT rev (the score calculated by accepting the reverse patterns correctly). 
There was a significant relationship between duration of implant use and temporal ordering performance 
CONCLUSION: In this study, children with CI cannot perform as well as normal-hearing peers on temporal 
processing tasks, even if they had started to use their CIs at an early age. It is important to evaluate temporal 
processing in implanted individuals and to guide auditory training considering the evaluation results.
Am J Otolaryngol. 2020 Mar - Apr;41(2):102379. doi: 10.1016/j.amjoto.2019.102379. Epub 2019 Dec 19. 
Experience with cholesteatoma behind an intact tympanic membrane in children.
Urík M, Kaliariková A, Machač J, Jurajda M.
INTRODUCTION: To systematically investigate all surgeries for cholesteatoma behind an intact tympanic 
membrane at our department. To identify predictive factors that can help the surgeon to plan surgery, surgical 
techniques, and follow-up treatment. 
MATERIAL AND METHODS: This retrospective study evaluates 21 child patients, who were operated in the 
period 2007-2017 on for cholesteatoma behind an intact tympanic membrane. 
RESULTS: A total of 202 primary operations were performed for cholesteatoma. In 21 cases (10,4%) there was 
a cholesteatoma behind an intact tympanic membrane and in 11 (5,45%) cases of it there was the congenital 
cholesteatoma. The most frequently affected area was the anterior-superior quadrant. The preoperative hearing 
loss increased significantly with disease severity (I-IV by Potsic). 
CONCLUSIONS: The classification system according to Potsic is sufficient and fully corresponds to the surgeon’s 
needs. It has been clearly shown that a higher CC stage is associated with worse postoperative hearing results.
Cochrane Database Syst Rev. 2020 Jan 21;1:CD010885. doi: 10.1002/14651858.CD010885.pub5. 
Different infusion durations for preventing platinum-induced hearing loss in children with 
cancer.
van As JW, van den Berg H, van Dalen EC.
BACKGROUND: Platinum-based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of 
these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the most important adverse 
effects is the occurrence of hearing loss or ototoxicity. In an effort to prevent this ototoxicity, different platinum 
infusion durations have been studied. This review is the third update of a previously published Cochrane Review. 
OBJECTIVES: To assess the effects of different durations of platinum infusion to prevent hearing loss or tinnitus, 
or both, in children with cancer. Secondary objectives were to assess possible effects of these infusion durations 
on: a) anti-tumour efficacy of platinum-based therapy, b) adverse effects other than hearing loss or tinnitus, and c) 
quality of life. 
SEARCH METHODS: We searched the electronic databases Cochrane Central Register of Controlled Trials 
(CENTRAL; the Cochrane Library 14 November 2019), MEDLINE (PubMed) (1945 to 14 November 2019) and 
Embase (Ovid) (1980 to 14 November 2019). In addition, we handsearched reference lists of relevant articles and 
we assessed the conference proceedings of the International Society for Paediatric Oncology (2009 up to and 
including 2019) and the American Society of Pediatric Hematology/Oncology (2014 up to and including 2019). We 
scanned ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (WHO 
ICTRP; apps.who.int/trialsearch) for ongoing trials (both searched on 4 November 2019). 
SELECTION CRITERIA: Randomised controlled trials (RCTs) or controlled clinical trials (CCTs) comparing 
different platinum infusion durations in children with cancer. Only the platinum infusion duration could differ 
between the treatment groups. 
DATA COLLECTION AND ANALYSIS: Two review authors independently performed the study selection, ‘Risk of bias’ 
assessment and GRADE assessment of included studies, and data extraction including adverse effects. Analyses 
were performed according to the guidelines of the Cochrane Handbook for Systematic Reviews of Interventions. 
MAIN RESULTS: We identified one RCT and no CCTs; in this update no additional eligible studies were identified. 
The RCT (total number of children = 91) evaluated the use of a continuous cisplatin infusion (N = 43) versus a 
one-hour bolus cisplatin infusion (N = 48) in children with neuroblastoma. For the continuous infusion, cisplatin 
was administered on days one to five of the cycle, but it is unclear if the infusion duration was a total of five days. 
Risk of bias was present. Only results from shortly after induction therapy were provided. No clear evidence of a 
difference in hearing loss (defined as asymptomatic and symptomatic disease combined) between the different 
infusion durations was identified as results were imprecise (risk ratio (RR) 1.39, 95% confidence interval (CI) 
0.47 to 4.13, low-quality evidence). Although the numbers of children were not provided, it was stated that tumour 
response was equivalent in both treatment arms. With regard to adverse effects other than ototoxicity, we were 
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only able to assess toxic deaths. Again, the confidence interval of the estimated effect was too wide to exclude 
differences between the treatment groups (RR 1.12, 95% CI 0.07 to 17.31, low-quality evidence). No data were 
available for the other outcomes of interest (i.e. tinnitus, overall survival, event-free survival and quality of life) or 
for other (combinations of) infusion durations or other platinum analogues. 
AUTHORS’ CONCLUSIONS: Since only one eligible RCT evaluating the use of a continuous cisplatin infusion 
versus a one-hour bolus cisplatin infusion was found, and that had methodological limitations, no definitive 
conclusions can be made. It should be noted that ‘no evidence of effect’, as identified in this review, is not the 
same as ‘evidence of no effect’. For other (combinations of) infusion durations and other platinum analogues no 
eligible studies were identified. More high-quality research is needed.
Int J Pediatr Otorhinolaryngol. 2020 Feb 4;132:109909. doi: 10.1016/j.ijporl.2020.109909. 
Correlation of air-bone gap and size of Enlarged Vestibular Aqueduct in children.
Van Beck J, Chinnadurai S, Morrison AK, Zuniga MG, Smith B, Lohse CM, McCaslin D.
OBJECTIVE: Enlarged vestibular aqueduct (EVA) is an inner ear malformation that represents an important 
cause of pediatric hearing loss. While certain elements in the history or audiogram may suggest EVA, it is most 
often diagnosed using computed tomography (CT). The present investigation was conducted to determine if the 
size of the audiometric air-bone gap (ABG) is correlated with the size of the vestibular aqueduct in the pediatric 
population using three vestibular aqueduct measurements. These included the fundus, midpoint, and porous 
widths of the vestibular aqueduct. 
STUDY DESIGN: This is a retrospective cohort study. 
SETTING: This study took place at a tertiary care referral center. 
PATIENTS: Fifty-five children (33 female; 22 male) with a confirmed diagnosis of unilateral or bilateral EVA as 
determined by prior imaging of the inner ear were included in the study. 
MAIN OUTCOME MEASURES: Associations of EVA measurements with ABGs at 0.5 and 1 kHz were evaluated 
using Pearson correlation coefficients. 
RESULTS: All of the correlation coefficients were positive, indicating that as EVA measurements increased so did 
the ABG. Only the correlation between fundus width and ABG at 1 kHz was not statistically significant. 
CONCLUSIONS: ABGs measured during audiometric testing correlate with the size of the EVA and ABGs can 
be clinical predictors of the severity of the bony abnormality. These data support the third window theory of 
conductive hearing loss in pediatric EVA.
BMJ Case Rep. 2019 Dec 1;12(11). pii: e231978. doi: 10.1136/bcr-2019-231978. 
Neonatal cholestasis, hyperferritinemia, hypoglycemia and deafness: a diagnostic challenge.
van Westering-Kroon E, Heijligers M, Hütten MC.
ABSTRACT: Neonatal conjugated hyperbilirubinemia is a diagnostic challenge. A full term, small for gestational 
age boy presented with cholestasis, hypoglycemia, hyperferritinemia and severe bilateral deafness. Diagnostic 
work-up revealed two hereditary diseases: alpha-1-antitrypsin deficiency (PI*ZZ genotype) and autosomal 
recessive deafness type 3 (compound heterozygous MYO15A gene mutation). In addition, we found late 
hypoglycemia on full enteral feeding which complicated this case. Hyperferritinemia is an uncommon finding in 
newborn cholestasis without liver failure.
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Feb;34(2):113-118. doi: 10.13201/j.issn.1001-1781.2020.02.004. 
[Article in Chinese]
Analysis of genotypes and hearing phenotypes of mutation infants with deafness.
Wang X, Zhao X, Huang L, Wen C, Wang X, Cheng X.
OBJECTIVE: The aim of this study is to explore the genotype and hearing phenotype of deaf infants with 
mutation of GJB2 gene. 
METHOD: Subjects were 121 infants with GJB2 gene mutations who were treated in the Children’s Hearing 
Diagnosis Center of Beijing Tongren hospital. All subjects were accepted to undertake the universal newborns 
hearing screening (UNHS) and series of objective audiometry, including auditory brainstem response, distortion 
product otoacoustic emission, auditory steady-state response and other audiological tests. All subjects were 
screened for nine pathogenic variants in four genes or all exons of the GJB2 gene, and then were diagnosed as 
infants with GJB2 gene mutations. Initially, analyzing their genotypes and hearing phenotypes generally. Then, the 
subjects were divided into two groups according to the genotypes: T/T group (truncated/truncated mutations, 89 
cases) and T/NT group (truncated/non-truncated mutations, 32 cases). Chi-square test was used to analyze the 
results of UNHS, hearing degree, audiogram patterns and symmetry/asymmetry of binaural hearing phenotype. 
Eventually, analyzing the results of UNHS. 
RESULT: The most common truncated mutation was c.235delC (64.88%, 157/242 and the most common non-
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truncated mutation was c.109G>A (11.16%, 27/242. The homozygous mutation of c.235delC/c.235delC was 
the dominant in T/T group (38.84%, 47/121, and the compound heterozygous mutation of c.235delC/c.109G>A 
was the dominant in T/NT group (18.18%, 22/121. 81.82% (99/121 of subjects failed in UNHS, including 74.38% 
(90/121 with bilateral reference, 7.44% (9/121 with a single pass. The refer rate of UNHS of group T/T and T/NT 
were 86.52% (77/89 and 68.75%, respectively. There was a statistically significant difference between the two 
groups (P<0.05. 85.95% (104/121 of subjects were diagnosed as hearing loss and 14.05% (17/121 of subjects 
were diagnosed as normal hearing. The degree of hearing loss: profound, severe, moderate and mild were 
31.40% (38/121, 19.01% (23/121, 24.79% (30/121 and 10.74% (13/121, respectively. There was no subjects 
with normal hearing in T/T group and individuals with severe and profound hearing loss accounted for the highest 
proportion (65.17%, 58/89, while in T/NT group, normal hearing accounted for 53.13% (17/32 and mild and 
moderate hearing loss accounted for the highest proportion (37.5%, 12/32. There was statistically significant 
difference between the two groups (P<0.05. Of 104 patients (208 ears with hearing loss, the audiogram patterns: 
flat, descending, ascending, residual, Valley and other types were 49.03% (102/208, 12.02% (25/208, 8.65% 
(18/208, 7.69% (16/204, 3.36% (7/204 and 19.23% (40/204, respectively. The two most common types in T/T 
group were flat (47.19%, 84/178 and other types (20.22%, 36/178, while in T/NT group were flat (60.00%, 18/30 
and ascending (20.00%, 6/30. There was statistically significant difference between the two groups (P<0.05. 
There were 50 cases (48.07% with symmetrical hearing phenotype and 54 cases (51.93%) with asymmetrical 
hearing phenotype. Asymmetry was predominant in T/T group (53.93%, 48/89, and symmetry was predominant 
in T/NT group (60.00%, 9/15. There was no statistically significant difference between the two groups (P>0.05. 
CONCLUSION: In this study, c.235delC/c.235delC homozygous mutation was dominant in T/T group and 
c.235delC/c.109G>A heterozygous mutation was dominant in T/NT Group. The hearing phenotypes in T/T group 
were mostly bilateral asymmetric severe hearing loss, and those in T/NT Group were bilateral symmetric mild to 
moderate hearing loss, special attention should be paid to the audiological characteristics of different genotypes.
Otolaryngol Head Neck Surg. 2020 Apr 14:194599820915741. doi: 10.1177/0194599820915741. 
Cognitive and Behavioral Functioning in Hearing-Impaired Children with and without 
Language Delay.
Williams A, Pulsifer M, Tissera K, Mankarious LA.
ABSTRACT: Poor language development in patients with sensorineural hearing loss (SNHL) may be related to an 
auditory deficit and/or other neurologic condition that influences the ability to communicate. A retrospective chart 
review of children (mean age = 4.0 years) with congenital, bilateral SNHL was performed to assess for linguistic 
and nonlinguistic neurodevelopmental differences between those who were language-impaired (LI) versus non-
language-impaired (NLI). Language, neurodevelopmental functioning, and behavior were assessed. Twenty-two 
patients were identified: 12 were LI and 10 were NLI. Average pure-tone thresholds and nonverbal intelligence 
were not different between the language groups, but the LI group demonstrated significantly lower median overall 
adaptive skills, personal living skills, and motor skills. Behavioral dysregulation was significantly higher in the 
LI versus NLI group (58% vs 10%; P = .031), although the median neurodevelopmental scores did not differ 
significantly. These findings introduce the possibility that nonlinguistic processing deficit(s) may be confounding 
the ability to develop language.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):269-276. doi: 10.3760/cma.j.issn.1003-9406.2020.03.008. 
[Article in Chinese]
Clinical practice guidelines for hereditary non-syndromic deafness.
Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical 
Genetics Branch Of Chinese Medical Association, Yuan H, Dai P, Liu Y, Yang T.
ABSTRACT: Genetic factors are a common cause for non-syndromic hearing loss (NSHL). Along with the 
development and maturity of molecular techniques, genetic diagnosis and counseling is increasingly affecting the 
clinical practice of NSHL. Newborn hearing screening has facilitated early detection of affected children, whilst 
genetic screening has enabled identification of the cause of NSHL, and genetic diagnosis and consultation can 
promote early intervention of deafness. So far 110 pathogenic genes of NSHL have been discovered, though 
there are still many challenges lying in its clinical identification. The development of genetic counseling and 
prenatal diagnosis has put forward greater requirements for genetic testing and data interpretation. This guideline 
has summarized the incidence, mutational spectrum, inheritance mode, pathogenesis, clinical manifestation, 
genotype - phenotype correlation, genetic testing, treatment and intervention, as well as risk assessment for 
NSHL, with an aim to provide a reference for genetic consultants, clinical otologists and professionals engaged in 
genetic testing.
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Clin Infect Dis. 2020 Mar 17;70(7):1379-1384. doi: 10.1093/cid/ciz413. 
Contribution of Congenital Cytomegalovirus Infection to Permanent Hearing Loss in a Highly 
Seropositive Population: The Brazilian Cytomegalovirus Hearing and Maternal Secondary 
Infection Study.
Yamamoto AY, Anastasio ART, Massuda ET, Isaac ML, Manfredi AKS, Cavalcante JMS, Carnevale-
Silva A, Fowler KB, Boppana SB, Britt WJ, Mussi-Pinhata MM.
BACKGROUND: The exact contribution of congenital cytomegalovirus infection (cCMVI) to permanent hearing 
loss (HL) in highly seropositive populations is unknown. We determined the contribution of cCMVI to HL and 
estimated the effectiveness of newborn hearing screening (HS) in identifying neonates with CMV-related HL. 
METHODS: A total of 11 900 neonates born from a population with ≥97% maternal seroprevalence were screened 
for cCMVI and HL. cCMVI was confirmed by detection of CMV-DNA in saliva and urine at age <3 weeks. 
RESULTS: Overall, 68 (0.6%; 95% confidence interval [CI], 0.4-0.7) neonates were identified with cCMVI. Of the 
91 (0.8%) newborns who failed the HS, 24 (26.4%) were confirmed with HL, including 7 (29.2%; 95% CI, 17.2-
59.3) with cCMVI. Another newborn with cCMVI passed the HS but was confirmed with HL at age 21 days. Of 
the 62 neonates with cCMVI who underwent a complete hearing evaluation, 8 (12.9%; 95% CI, 6.7-23.4) had 
HL and most (7/8; 87.5%; 95% CI, 46.6-99.7) were identified by HS. The rate of CMV-related HL was 8 per 11 
887 neonates (0.7 per 1000 live births). The prevalence ratio of HL among neonates with cCMVI compared to 
CMV-uninfected neonates was 89.5 (95% CI, 39.7-202.0). No late-onset cCMVI-related HL was detected during a 
median follow-up of 36 months. 
CONCLUSIONS: cCMVI is an important cause of HL in childhood in all settings. Integrating targeted cCMVI 
screening among neonates who fail a HS could be a reasonable, cost-effective strategy to identify newborns with 
early-onset cCMVI-related HL.
Otolaryngol Head Neck Surg. 2020 Mar 31:194599820913507. doi: 10.1177/0194599820913507. 
Cost-effectiveness of School Hearing Screening Programs: A Scoping Review.
Yong M, Liang J, Ballreich J, Lea J, Westerberg BD, Emmett SD.
OBJECTIVE: School hearing screening is a public health intervention that can improve care for children who 
experience hearing loss that is not detected on or develops after newborn screening. However, implementation 
of school hearing screening is sporadic and supported by mixed evidence to its economic benefit. This scoping 
review provides a summary of all published cost-effectiveness studies regarding school hearing screening 
programs globally. At the time of this review, there were no previously published reviews of a similar nature. 
DATA SOURCES: A structured search was applied to 4 databases: PubMed (Medline), Embase, CINAHL, and 
Cochrane Library.
REVIEW METHODS: The database search was carried out by 2 independent researchers, and results were 
reported in accordance with the PRISMA-ScR checklist and the JBI methodology for scoping reviews. Studies that 
included a cost analysis of screening programs for school-aged children in the school environment were eligible 
for inclusion. Studies that involved evaluations of only neonatal or preschool programs were excluded. 
RESULTS: Four of the 5 studies that conducted a cost-effectiveness analysis reported that school hearing 
screening was cost-effective through the calculation of incremental cost-effectiveness ratios (ICERs) via either 
quality- or disability-adjusted life years. One study reported that a new school hearing screening program 
dominated the existing program; 2 studies reported ICERs ranging from 1079 to 4304 international dollars; and 1 
study reported an ICER of £2445. One study reported that school-entry hearing screening was not cost-effective 
versus no screening. 
CONCLUSION: The majority of studies concluded that school hearing screening was cost-effective. However, 
significant differences in methodology and region-specific estimates of model inputs limit the generalizability of 
these findings.
Int J Pediatr Otorhinolaryngol. 2020 Mar;130:109845. doi: 10.1016/j.ijporl.2019.109845. Epub 2019 Dec 24. 
Parents’ satisfaction with a trial of a newborn hearing screening programme in Jordan.
Zaitoun M, Nuseir A.
OBJECTIVE: This study examines parents’ satisfaction level toward a trial of a newborn hearing screening 
programme (NHSP) that was applied in King Abdullah II University Hospital (KAUH) in Jordan over one year. 
This is the first study that investigated parents’ satisfaction toward a hearing screening programme in the Arab 
countries, and the results will improve any future screening programmes in the Arabian region. 
METHOD: The main tool for this study was a questionnaire that was translated and modified from the original 
version of the Parental Satisfaction with the Newborn Hearing Screening Programme (PSQ-NHSPs1). The 
questionnaire consisted of 19 items covering five main aspects of the NHSP. The parents’ responses were not 
anonymously given where the parents whose children had undergone the hearing screening were contacted by 
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phone using the data record of the hospital. 
RESULTS: The majority of the parents were very satisfied with the programme overall and showed great support 
and appreciation for the effort in testing their babies and increasing their awareness. The satisfaction levels 
varied among the specific aspects of the programme. Good portion of the parents did not receive the brochure 
containing information about the screening, and almost half of them did not know the results of the hearing 
screening. 
CONCLUSION: Parents were overall satisfied with neonatal hearing screening programme that was conducted 
at KAUH. However, parents were less satisfied with information related to the test procedure and results. Parents’ 
responses in this study could be used to improve any future hearing screening program in Jordan or in the Arab 
countries.
